Element Solutions (ESI) 10-Q 6 Aug 14 2014 Q2 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	6 Months Ended
	Jun. 30, 2014	Aug. 01, 2014
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'Platform Specialty Products Corp	'
Document Type	'10-Q	'
Current Fiscal Year End Date	'--12-31	'
Entity Common Stock, Shares Outstanding	'	137,300,222
Amendment Flag	'false	'
Entity Central Index Key	'0001590714	'
Entity Current Reporting Status	'Yes	'
Entity Voluntary Filers	'No	'
Entity Filer Category	'Non-accelerated Filer	'
Entity Well-known Seasoned Issuer	'No	'
Document Period End Date	30-Jun-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q2	'

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (Unaudited) (USD $)	2 Months Ended	3 Months Ended		6 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Operating expenses:	'	'	'	'	'
Restructuring	'	$404	$46	$404	$1,652
Other (expense) income:	'	'	'	'	'
Loss on extinguishment of debt	'	'	18,788	'	'
Weighted average shares outstanding (In thousands)	'	'	'	'	'
Basic (in Shares)	117,937	128,595	'	'	'
Diluted (in Shares)	117,937	128,595	'	'	'
Successor [Member]	'	'	'	'	'
Net sales	'	189,132	'	372,858	'
Cost of sales	'	92,445	'	191,949	'
Gross profit	'	96,687	'	180,909	'
Operating expenses:	'	'	'	'	'
Selling, technical, general and administrative	'	84,779	'	158,811	'
Research and development	'	5,898	'	12,096	'
Restructuring	'	404	'	404	'
Total operating expenses	'	91,081	'	171,311	'
Operating profit (loss)	'	5,606	'	9,598	'
Other (expense) income:	'	'	'	'	'
Interest, net	'	-7,662	'	-15,404	'
Other (expense) income, net	'	-512	'	-601	'
	'	-8,174	'	-16,005	'
(Loss) income before income taxes, non-controlling interests and accrued payment-in-kind dividends on cumulative preferred shares	'	-2,568	'	-6,407	'
Income tax benefit (provision)	'	4,056	'	1,947	'
Net income (loss)	-80	1,488	'	-4,460	'
Net income attributable to the non-controlling interests	'	-1,864	'	-3,334	'
Net (loss) income attributable to common shareholders	'	-376	'	-7,794	'
Net loss attributable to common shares	'	-376	'	-7,794	'
Earnings (loss) per share	'	'	'	'	'
Basic (in Dollars per share)	'	$0	'	($0.07)	'
Diluted (in Dollars per share)	'	$0	'	($0.07)	'
Weighted average shares outstanding (In thousands)	'	'	'	'	'
Basic (in Shares)	'	128,595	'	117,937	'
Diluted (in Shares)	'	128,595	'	117,937	'
Successor From Inception [Member]	'	'	'	'	'
Operating expenses:	'	'	'	'	'
Selling, technical, general and administrative	97	'	'	'	'
Total operating expenses	97	'	'	'	'
Operating profit (loss)	-97	'	'	'	'
Other (expense) income:	'	'	'	'	'
Interest, net	17	'	'	'	'
Other (expense) income, net	17	'	'	'	'
	17	'	'	'	'
(Loss) income before income taxes, non-controlling interests and accrued payment-in-kind dividends on cumulative preferred shares	-80	'	'	'	'
Net income (loss)	-80	'	'	'	'
Net (loss) income attributable to common shareholders	-80	'	'	'	'
Net loss attributable to common shares	-80	'	'	'	'
Earnings (loss) per share	'	'	'	'	'
Basic (in Dollars per share)	0	'	'	'	'
Diluted (in Dollars per share)	0	'	'	'	'
Weighted average shares outstanding (In thousands)	'	'	'	'	'
Basic (in Shares)	88,529	'	'	'	'
Diluted (in Shares)	88,529	'	'	'	'
Predecessor [Member]	'	'	'	'	'
Net sales	'	'	189,992	'	372,124
Cost of sales	'	'	93,451	'	182,269
Gross profit	'	'	96,541	'	189,855
Operating expenses:	'	'	'	'	'
Selling, technical, general and administrative	'	'	53,989	'	109,969
Research and development	'	'	5,874	'	11,826
Restructuring	'	'	46	'	1,652
Total operating expenses	'	'	59,909	'	123,447
Operating profit (loss)	'	'	36,632	'	66,408
Other (expense) income:	'	'	'	'	'
Interest, net	'	'	-12,849	'	-24,567
Loss on extinguishment of debt	'	'	-18,788	'	-18,788
Other (expense) income, net	'	'	-2,999	'	588
	'	'	-34,636	'	-42,767
(Loss) income before income taxes, non-controlling interests and accrued payment-in-kind dividends on cumulative preferred shares	'	'	1,996	'	23,641
Income tax benefit (provision)	'	'	-7,760	'	-14,068
Net income (loss)	'	'	-5,764	'	9,573
Net income attributable to the non-controlling interests	'	'	-91	'	-180
Net (loss) income attributable to common shareholders	'	'	-5,855	'	9,393
Accrued payment-in-kind dividend on cumulative preferred shares	'	'	-9,278	'	-21,072
Net loss attributable to common shares	'	'	($15,133)	'	($11,679)

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Comprehensive Income (Unaudited) (USD $)	3 Months Ended	6 Months Ended	2 Months Ended	3 Months Ended	6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2013	Jun. 30, 2013
	Successor [Member]	Successor [Member]	Successor From Inception [Member]	Predecessor [Member]	Predecessor [Member]
Net income (loss)	$1,488	($4,460)	($80)	($5,764)	$9,573
Other comprehensive income (loss) income, before tax	'	'	'	'	'
Foreign currency translation adjustments	19,688	22,975	'	-5,453	-22,009
Unrealized (loss) gain on available for sale securities	57	6	'	-96	49
Pension and postretirement plan	'	217	'	'	'
Derivative financial instruments revaluation	-178	-163	'	130	-650
Total other comprehensive income (loss), before tax	19,567	23,035	'	-5,419	-22,610
Income tax benefit (provision) on comprehensive income (loss)	53	72	'	-12	210
Other comprehensive income (loss), net of tax	19,620	23,107	'	-5,431	-22,400
Comprehensive income attributable to the non-controlling interests	-3,209	-4,674	'	-91	-148
Comprehensive income (loss) attributable to common shareholders	$17,899	$13,973	($80)	($11,286)	($12,975)

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (Unaudited) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Assets	'	'
Cash & cash equivalents	$642,760	$123,040
Accounts receivable, net of allowance for doubtful accounts of $10,430 and $10,113 at June 30, 2014 and December 31, 2013, respectively	142,011	140,525
Inventories	80,511	89,618
Prepaid expenses & other current assets	24,262	30,269
Total current assets	889,544	383,452
Property, plant & equipment, net	133,641	136,166
Goodwill	1,004,354	989,808
Intangible assets, net	699,443	720,302
Other assets	39,707	30,426
Total assets	2,766,689	2,260,154
Liabilities & Stockholders' Equity	'	'
Accounts payable	56,990	56,156
Accrued salaries, wages and employee benefits	17,136	22,656
Current installments of long-term debt	7,953	7,958
Accrued income taxes payable	3,434	6,669
Accrued expenses and other current liabilities	29,812	26,234
Total current liabilities	115,325	119,673
Long-term debt	740,497	744,291
Long-term retirement benefits, less current portion	23,812	25,129
Long-term deferred income taxes	166,298	169,800
Long-term contingent consideration	58,600	34,800
Other long-term liabilities	35,956	30,387
Total liabilities	1,140,488	1,124,080
Redeemable 401(k) plan interest	'	20,972
Stockholders' Equity	'	'
Preferred shares (2,000,000 designated as Series A), 5,000,000 shares authorized, 2,000,000 shares issued and outstanding at June 30, 2014 and December 31, 2013, respectively	20	'
Common shares, $0.01 par value (effective January 23, 2014), 400,000,000 shares authorized, 137,290,980 and 103,571,941 shares issued and outstanding at June 30, 2014 and December 31, 2013, respectively	1,353	'
Additional paid-in capital	1,703,483	1,212,038
Accumulated deficit	-202,016	-194,222
Accumulated other comprehensive income	24,372	1,265
Total stockholders equity	1,527,212	1,019,081
Non-controlling interests	98,989	96,021
Total equity	1,626,201	1,115,102
Total liabilities, redeemable 401(k) plan interest and stockholders' equity	$2,766,689	$2,260,154

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, except Share data, unless otherwise specified
Accounts receivable, allowance for doubtful accounts (in Dollars)	$10,430	$10,113
Preferred shares authorized	5,000,000	5,000,000
Preferred shares, shares issued	2,000,000	2,000,000
Preferred shares, shares outstanding	2,000,000	2,000,000
Common shares, par value (in Dollars per share)	$0.01	$0.01
Common shares authorized	400,000,000	200,000,000
Common shares issued	137,290,980	103,571,941
Common shares outstanding	137,290,980	103,571,941
Series A Preferred Stock [Member]	'	'
Preferred shares authorized	2,000,000	2,000,000

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended	2 Months Ended	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2013
	Successor [Member]	Successor From Inception [Member]	Predecessor [Member]
Cash flows from operating activities:	'	'	'
Net (loss) income	($4,460,000)	($80,000)	$9,573,000
Depreciation and amortization	38,286,000	'	19,741,000
Deferred income taxes	-13,801,000	'	4,954,000
Non-cash fair value adjustment to contingent consideration	23,800,000	'	'
Manufacturer's profit in inventory adjustment	11,956,000	'	'
Loss on extinguishment of debt	'	'	18,788,000
Other, net	1,568,000	27,000	3,153,000
Changes in assets & liabilities, net of acquisitions:	'	'	'
Accounts receivable	-1,990,000	'	-10,620,000
Inventories	-1,700,000	'	-2,818,000
Accrued expenses	-5,415,000	'	-3,351,000
Other assets and liabilities	970,000	-2,000	-2,173,000
Net cash flows provided by (used in) operating activities	49,214,000	-55,000	37,247,000
Cash flows from investing activities:	'	'	'
Capital expenditures, net	-4,587,000	'	-3,687,000
Purchases of marketable securities	'	-359,933,000	'
Acquisition of business, net	4,827,000	'	'
Other, net	'	'	1,057,000
Net cash flows provided by (used in) investing activities	240,000	-359,933,000	-2,630,000
Cash flows from financing activities:	'	'	'
Proceeds from issuance of debt, net of discount and fees	'	'	1,109,513,000
Repayments of borrowings	-3,795,000	'	-624,396,000
Repurchase of Predecessor Series A preferred stock	'	'	-270,167,000
Payment of Predecessor Series A preferred stock	'	'	-229,833,000
Escrowed funds for debt repayment	'	'	-105,864,000
Proceeds from issuance of common stock, net	473,625,000	861,218,000	'
Proceeds from issuance of preferred stock, net	'	20,000,000	'
Payment of debt financing fees	'	'	-12,571,000
Other, net	136,000	'	-287,000
Net cash flows provided by (used in) financing activities	469,966,000	881,218,000	-133,605,000
Effect of exchange rate changes on cash and cash equivalents	300,000	'	-1,455,000
Net increase (decrease) in cash and cash equivalents	519,720,000	521,230,000	-100,443,000
Cash and cash equivalents at beginning of period	123,040,000	'	143,351,000
Cash and cash equivalents at end of period	$642,760,000	$521,230,000	$42,908,000

Note_1_Basis_of_Presentation_a

Note 1 - Basis of Presentation and Significant Accounting Policies	6 Months Ended
	Jun. 30, 2014
Disclosure Text Block [Abstract]	'
Business Description and Basis of Presentation [Text Block]	'
	(Unaudited)
	1. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES
	Platform Specialty Products Corporation and its subsidiaries (“Platform,” the “Company,” “we” or “us”) (formerly named Platform Acquisition Holdings Limited) is a global producer of high-technology specialty chemical products and provider of technical services and currently operates through its indirect subsidiary, MacDermid, Incorporated (“MacDermid” or the “Predecessor”).  Platform was originally incorporated with limited liability under the laws of the British Virgin Islands under the BVI Companies Act on April 23, 2013. Until its acquisition of MacDermid on October 31, 2013, the Company had neither engaged in any operations nor generated any income. The Company selected December 31 as its fiscal year end.
	On October 31, 2013, Platform indirectly acquired substantially all of the equity of, MacDermid Holdings, LLC (“MacDermid Holdings”), which owned approximately 97% of MacDermid (the “MacDermid Acquisition”). As a result, Platform became a holding company for the MacDermid business.  We acquired the remaining 3% of MacDermid on March 4, 2014, pursuant to the terms of an Exchange Agreement, dated October 25, 2013, between us and the fiduciaries of the MacDermid, Incorporated Profit Sharing and Employee Savings Plan (the “MacDermid Savings Plan”).  Concurrently with the closing of the MacDermid Acquisition, we changed our name to Platform Specialty Products Corporation. On January 22, 2014, we changed our jurisdiction of incorporation from the British Virgin Islands to Delaware (the “Domestication”) and on January 23, 2014, our shares of common stock, par value $0.01 per share (“Common Stock”) began trading on the New York Stock Exchange (“NYSE”) under the ticker symbol “PAH”.
	The accompanying unaudited condensed consolidated interim financial statements and related information included herein are (1) for Platform as of June 30, 2014 and December 31, 2013 and for the period from April 1, 2014 through June 30, 2014 (the “Successor Quarterly Period”) and January 1, 2014 through June 30, 2014 (the “Successor Six Month Period”), (2) for Platform, prior to the completion of the MacDermid Acquisition, for the period from Inception (April 23, 2013) through June 30, 2013 (the “Platform Preacquisition Period”), and (3) for MacDermid for the period from April 1, 2013 through June 30, 2013 (the “Predecessor Quarterly Period”) and January 1, 2013 through June 30, 2013 (the “Predecessor Six Month Period”).
	These unaudited condensed consolidated interim financial statements and related information have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the applicable rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. These unaudited condensed consolidated interim financial statements reflect all adjustments that are, in the opinion of management, normal and recurring and necessary for a fair statement of the results of operations. These unaudited condensed consolidated interim financial statements should be read in conjunction with the consolidated financial statements and the related notes thereto included in the Company’s latest Annual Report on Form 10-K for the fiscal year ended December 31, 2013.
	Certain reclassifications and revisions have been made to the Consolidated Balance Sheet at December 31, 2013 and corresponding disclosures in accordance with Financial Accounting Standards Board (the “FASB”)  ASC Topic 805, “Business Combinations” to reflect retrospective purchase accounting adjustments to the preliminary estimated fair values of certain assets acquired and liabilities assumed upon completion of the MacDermid Acquisition in addition to accumulated other comprehensive income. See Note 2 – “Acquisitions of Businesses” for further discussion.”
	Accounting Policies Recently Adopted and Pending Pronouncements
	In May 2014, the FASB issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers (Topic 606)” which 1) removes inconsistencies and weaknesses in revenue requirements, 2) provides a more robust framework for addressing revenue issues, 3) improves comparability of revenue recognition practices across entities, industries, jurisdictions, and capital markets, 4) provides more useful information to users of financial statements through improved disclosure requirements and 5) simplifies the preparation of financial statements by reducing the number of requirements to which an entity must refer.  The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2016. The Company is in the process of evaluating the impact of this new ASU.
	In March 2013, the FASB issued ASU No. 2013-05, “Foreign Currency Matters (Topic 830): Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity, (a consensus of the FASB Emerging Issues Task Force)” which resolves diversity in practice regarding the release of the cumulative translation adjustment into net income when a parent either sells a part or all of its investments in a foreign entity. In addition, the standard resolves diversity in practice for the treatment of business combinations achieved in stages involving a foreign entity. The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2013. The adoption of this new ASU did not have a material impact on our consolidated financial position, results of operations or cash flows in the Successor Quarterly or Six Month Periods.

Note_2_Acquisitions_of_Busines

Note 2 - Acquisitions of Businesses	6 Months Ended
	Jun. 30, 2014
Business Combinations [Abstract]	'
Business Combination Disclosure [Text Block]	'
	2.  ACQUISITIONS OF BUSINESSES
	MacDermid Acquisition
	On October 31, 2013, the Company completed the MacDermid Acquisition. The total consideration paid in connection with the MacDermid Acquisition and the acquisition of the approximately 3% of MacDermid equity interests (the “MacDermid Plan Shares”) not already held by MacDermid Holdings was approximately $1,800,000 (including the assumption of approximately $754,200 of indebtedness), plus (i) up to $100,000 of contingent consideration tied to achievement of EBITDA and stock trading price performance metrics over a seven-year period following the closing of the MacDermid Acquisition and (ii) an interest in certain MacDermid pending litigation. As a result of a favorable adjustment to the preliminary estimated working capital factored into the purchase price, the Company received a payment of approximately $8,540 in January 2014 which is reflected in “Acquisition of business, net” in the accompanying Condensed Consolidated Statements of Cash Flows.
	The fair value of contingent consideration was measured based on significant inputs not observable in the market, which are considered to be Level 3 inputs under the FASB ASC Topic 820 fair value hierarchy (see Note 10 - “Fair Value Measurements”). Key assumptions included in the fair value calculation of the EBITDA related earnout include a discount rate of approximately 2% and expected future value of payments of $60,000 calculated using a probability weighted EBITDA assessment with higher probability associated with the Company achieving the maximum EBITDA targets. Key assumptions included in the fair value calculation of the stock price related earnout include the fair value of Common Stock, the expected future value of payments of $40,000 and an assumption of volatility.  The stock price related earnout was calculated using a Monte Carlo simulation.  At the time of the MacDermid Acquisition, the fair value of the contingent payments was $35,500. As of June 30, 2014 and December 31, 2013, the fair value of the contingent consideration was $58,600 and $34,800, respectively, which was included in “Other long-term liabilities” in the accompanying Condensed Consolidated Balance Sheets. The $10,800 and $23,800 increase in fair value during the Successor Quarterly and Six Month Periods, respectively, which is recorded in “Selling, technical, general and administrative expenses” in the accompanying Condensed Consolidated Statements of Operations, was primarily due to the achievement of certain stock trading price performance metric targets of the contingent consideration arrangement.
	During the Successor Quarterly Period, the Company revised its allocations of the purchase price as follows:
	Purchase Price Allocation (in thousands):	Original			Revised			Revision
	Preliminary value assigned:
	Accounts receivable	$	147,400		$	147,400		$	-
	Inventories		115,300			115,300			-
	Other current assets		26,200			26,200			-
	Property, plant and equipment		142,800			140,900			(1,900	)
	Customer relationships		458,400			494,000			35,600
	Developed technology		155,000			164,200			9,200
	Tradenames		73,400			70,800			(2,600	)
	Goodwill		993,800			990,000			(3,800	)
	Other assets		30,800			28,300			(2,500	)
	Accounts payable		(55,900	)		(55,900	)		-
	Other current liabilities		(62,100	)		(62,000	)		100
	Long-term debt		(754,200	)		(754,200	)		-
	Non-current deferred tax liability		(140,700	)		(171,200	)		(30,500	)
	Contingent consideration		(35,500	)		(35,500	)		-
	Redeemable 401(k) plan interest		(21,000	)		(21,000	)		-
	Other liabilities		(66,500	)		(66,500	)		-
	Total purchase price	$	1,007,200		$	1,010,800		$	3,600
	The measurement period adjustments described above had a cumulative $1,500 impact to amortization expense which was recorded in the Successor Quarterly Period as the impact on prior periods was not material.
	Immediately prior to the closing of the MacDermid Acquisition, certain sellers of MacDermid, including certain officers of MacDermid (each, a “Retaining Holder”), executed a Retaining Holder Securityholders’ Agreement (a “RHSA”) with the Company pursuant to which they agreed to exchange their equity in MacDermid for equity in our subsidiary, Platform Delaware Holdings, Inc. (“PDH”), at an exchange rate of $11.00 per shares plus, (i) a proportionate share of the $100,000 contingent consideration described above and (ii) an interest in certain MacDermid pending litigation.  This 6.76% ownership has been accounted for as a non-controlling interest in the Company’s financial statements.  The Retaining Holders can exchange up to 25% of shares for Platform Common Stock beginning on November 1, 2014.  The number of potential shares of Common Stock issuable upon the exchange is approximately 8.8 million. This equity is classified as a “Non-controlling interest” in the accompanying Condensed Consolidated Balance Sheets.
	Upon the closing of the MacDermid Acquisition, the MacDermid Savings Plan retained a 3% interest in MacDermid. The fair value of the obligation to purchase these shares of $20,972 was recorded as a redeemable 401(k) interest in the mezzanine section of the Consolidated Balance Sheets at December 31, 2013 since it could be settled in either cash or stock. On March 4, 2014, pursuant to the terms of an Exchange Agreement, dated October 25, 2013, between the Company and the fiduciaries of the MacDermid Savings Plan, the Company acquired the remaining approximately 3% of the MacDermid Plan Shares for approximately $2,600 in cash (which is reflected in “Acquisition of business, net” in the accompanying Condensed Consolidated Statements of Cash Flows) and 1,670,386 shares of the Company’s Common Stock.
	Chemtura Acquisition
	On April 16, 2014, Platform entered into a Stock and Asset Purchase Agreement with Chemtura Corporation, a Delaware corporation (“Chemtura,” and together with certain of its subsidiaries, the “Sellers”) pursuant to which Platform agreed to acquire the Sellers’ agrochemicals business, Chemtura AgroSolutions, consisting of the manufacture, distribution, marketing and sale of seed treatments and crop protection in niche markets across seven major product lines – seed treatments, insecticides, miticides, herbicides, fungicides, plant growth regulators and adjuvants, for approximately $1,000,000, consisting of $950,000 in cash, subject to working capital and other adjustments, 2,000,000 shares of Common Stock and the assumption of certain liabilities by Platform (the “Chemtura Acquisition”). The closing of the Chemtura Acquisition is subject to the satisfaction or waiver of certain customary and other closing conditions for transactions of this type, including expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and approvals of government authorities. Subsequent to Platform’s announcement of the Chemtura Acquisition, Platform’s cash on hand position improved, primarily as a result of a private placement completed on May 21, 2014 (the “Private Placement”). See Note 11 – “Stockholders’ Equity” for more information.  As a result, the Company deposited $315,000 into an escrow account on July 3, 2014, which is restricted to the financing of the Chemtura Acquisition, and entered into an amended and restated debt commitment letter. See Note 8 – “Debt” for more information. In connection with the Chemtura Acquisition, the Company incurred approximately $9,900 in related expenses in the Successor Quarterly Period that are included in Selling, technical, general and administrative expenses in the Condensed Consolidated Statement of Operations. The Company is also committed to pay an additional $5,000 in finder’s fees upon the closing of the Chemtura Acquisition.
	Other
	During the quarter ended March 31, 2012, MacDermid acquired 95% of the stock of a specialty chemical business in Brazil for a total purchase price of $8,900. This business was acquired to complement the service and product offerings within Brazil and its balance sheet and results of operations have been included in the Performance Materials segment. During the first quarter of 2014, the remaining $1,114 purchase price was paid.

Note_3_Inventories

Note 3 - Inventories	6 Months Ended
	Jun. 30, 2014
Inventory Disclosure [Abstract]	'
Inventory Disclosure [Text Block]	'
	3.  INVENTORIES
	The major components of inventory were as follows:
		30-Jun-14		31-Dec-13
	Finished goods	$	49,880	$	58,360
	Raw materials and supplies		28,761		29,870
	Equipment		1,870		1,388
	Total inventory, net	$	80,511	$	89,618
	In connection with the MacDermid Acquisition, the fair value assessment of inventory resulted in an increase to finished goods of $35,868. During the Successor Period ended December 31, 2013, $23,992 was charged to cost of sales in the Consolidated Statement of Operations and $11,956 was charged to cost of sales in the Condensed Consolidated Statement of Operations during the three months ended March 31, 2014 based on our estimated inventory turnover.

Note_4_Property_Plant_and_Equi

Note 4 - Property, Plant and Equipment	6 Months Ended
	Jun. 30, 2014
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment Disclosure [Text Block]	'
	4.  PROPERTY, PLANT AND EQUIPMENT
	The major components of property, plant and equipment were as follows:
		30-Jun-14			31-Dec-13
	Land and leasehold improvements	$	27,860		$	29,946
	Buildings and improvements		36,290			38,914
	Machinery, equipment and fixtures		73,424			63,475
			137,574			132,335
	Less: accumulated depreciation		(14,202	)		(3,900	)
			123,372			128,435
	Construction in process		10,269			7,731
	Property, plant and equipment, net	$	133,641		$	136,166
	Depreciation expense of $5,392 and $3,162 was recorded during the Successor Quarterly Period and Predecessor Quarterly Period, respectively.  Depreciation expense of $8,965 and $6,314 was recorded during the Successor Six Month Period and Predecessor Six Month Period, respectively. There was no depreciation expense recorded for the Platform Preacquisition Period.

Note_5_Goodwill_and_Intangible

Note 5 - Goodwill and Intangible Assets	6 Months Ended
	Jun. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Goodwill and Intangible Assets Disclosure [Text Block]	'
	5.  GOODWILL AND INTANGIBLE ASSETS
	The changes in the carrying amount of goodwill by segment are as follows:
		Performance		Graphic			Total
		Materials		Solutions
	Balance, December 31, 2013	$	760,371	$	229,437		$	989,808
	Foreign currency translation and other		14,089		457			14,546
	Balance, June 30, 2014	$	774,460	$	229,894		$	1,004,354
	The carrying value of indefinite-lived intangible assets other than goodwill which consist solely of tradenames was $71,033 and $70,913 at June 30, 2014 and December 31, 2013, respectively.
	Intangible assets subject to amortization were as follows:
		30-Jun-14							31-Dec-13
		Gross Carrying		Accumulated			Net Book		Gross Carrying		Accumulated			Net Book
		Amount		Amortization and			Value		Amount		Amortization and			Value
				Foreign Exchange							Foreign Exchange
	Customer lists	$	494,000	$	(19,600	)	$	474,400	$	494,000	$	(6,420	)	$	487,580
	Developed technology		164,200		(10,190	)		154,010		164,200		(2,391	)		161,809
	Total	$	658,200	$	(29,790	)	$	628,410	$	658,200	$	(8,811	)	$	649,389
	Customer relationships have useful lives ranging from 8 to 20 years and developed technology has useful lives ranging between 7 to 10 years. This results in weighted average useful lives for customer relationships and developed technology, of approximately 16 years and 10 years, respectively, for an aggregate weighted average useful life of approximately 15 years at June 30, 2014.
	Amortization expense of $16,004 and $6,692 was recorded during the Successor Quarterly Period and Predecessor Quarterly Period, respectively. Amortization expense of $29,321 and $13,427 was recorded during Successor Six Month Period and Predecessor Six Month Period, respectively. There was no amortization expense recorded for the Platform Preacquisition Period.

Note_6_Equity_Compensation_Pla

Note 6 - Equity Compensation Plans	6 Months Ended
	Jun. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	'
	6.  EQUITY COMPENSATION PLANS
	Successor Period
	On June 12, 2014, the Company’s stockholders approved the Platform Specialty Products Corporation Amended and Restated 2013 Incentive Compensation Plan (the “2013 Plan”). At June 30, 2014, the total number of shares of Common Stock of our Company that may be subject to the granting of awards under the 2013 Plan based on the grants issued as discussed below is approximately 15,088,000 shares.
	On March 6, 2014, the Board of Directors (the “Board”) approved a grant of 329,823 restricted stock units (“RSUs”), effective on June 12, 2014 with approval of the 2013 Plan, to certain employees that cliff vest on December 31, 2020.  The RSUs are subject to an EBTIDA performance condition and a share price market condition that are similar in terms to those discussed in Note 2 – “Acquisitions of Businesses” related to the contingent consideration arrangement. Additionally, the number of shares of Common Stock to be issued is limited to a maximum cash value, requiring these awards to be classified as liabilities. The combined undiscounted maximum cash value of all RSU’s issued is approximately $7,100 which will be recognized as compensation expense through the vesting date. Compensation expense associated with these awards for the three and six month periods ended June 30, 2014 was approximately $92.
	On March 6, 2014, the Board approved a grant of 9,242 RSUs to directors of the Company, effective on June 12, 2014 with approval of the 2013 Plan, that immediately vested. Compensation expense of $262 associated with these awards was fully recognized in the three and six month periods ended June 30, 2014. On July 31, 2014 such RSUs were settled in shares of Common Stock and issued to the directors.
	On May 3, 2014, the Board approved a grant of 72,500 RSUs to certain employees of the Company, effective on June 12, 2014 with approval of the 2013 Plan, with a weighted average grant-date fair value per share of $28.36.  Approximately 69% of these RSUs vest on the date on which the Company files its financial statement on Form 10-K for the year ending December 31, 2019, while the remainder will vest under similar terms for the year ending December 31, 2017. The RSUs are subject to an EBTIDA performance condition that must be achieved in the final vesting year.  Compensation expense associated with these awards for the three and six month period ended June 30, 2014 was approximately $41.
	Effective March 6, 2014, the Board adopted the Platform Specialty Products Corporation 2014 Employee Stock Purchase Plan (the “ESPP”), which was approved by the Company’s stockholders on June 12, 2014. The Board approved a maximum of 5,178,815 shares of Common Stock, which were reserved and made available for issuance under the ESPP. As of June 30, 2014, no shares have been issued under the ESPP.
	Predecessor Period
	On January 29, 2013, the Predecessor authorized for issuance 5,000,000 Class C Junior Shares. The Class C Junior Shares were allocated to three tranches of 1,666,666 shares each and defined as Class C-1 Junior Shares, Class C-2 Junior Shares and Class C-3 Junior Shares (collectively, “C Shares”). The Class C-1 Junior Shares vested upon the grant date of January 29, 2013. Class C-2 Junior Shares were to vest on January 1, 2014 and the Class C-3 Junior Shares were to vest on January 1, 2015. The number of issued and awarded Class C Junior Shares was 4,890,000 shares or 1,630,000 shares each for the Class C-1 Junior Shares, Class C-2 Junior Shares and Class C-3 Junior Shares. The value of the C Shares was measured based upon the performance criteria in the operating agreement of MacDermid Holdings based on the estimated equity value of the Predecessor. The C Shares were to be paid in cash in accordance with the operating agreement of MacDermid Holdings upon a change in control, liquidating event or initial public offering. Payment for the C shares required continued employment through a change in control, liquidating event, or initial public offering. The C Shares were considered liability-classified awards with the related fair value recognized as compensation expense ratably over the performance period, with changes in the fair value of the award cumulatively adjusted through compensation expense each period. During the three and six months ended June 30, 2013 no compensation expense was recognized related to the C Shares as a change in control, liquidating event or initial public offering related to the Company (as defined in the MacDermid Holdings operating agreement) was not probable.  The estimated fair value of the Class C Shares (all tranches) was approximately $9,030 at June 30, 2013.

Note_7_Pension_PostRetirement_

Note 7 - Pension, Post-Retirement and Post-Employment Plans	6 Months Ended
	Jun. 30, 2014
Compensation and Retirement Disclosure [Abstract]	'
Pension and Other Postretirement Benefits Disclosure [Text Block]	'
	7.  PENSION, POST-RETIREMENT AND POST-EMPLOYMENT PLANS
	The components of net periodic pension and postretirement benefit costs for the Successor and Predecessor Quarterly and Six Month Periods are as follows:
		For the three months ended June 30,												For the six months ended June 30,
		2014						2013						2014						2013
		(Successor)						(Predecessor)						(Successor)						(Predecessor)
	Pension & SERP Benefits:	Domestic			Foreign			Domestic			Foreign			Domestic			Foreign			Domestic			Foreign
	Net periodic cost (benefit):
	Service cost	$	-		$	211		$	1,078		$	174		$	-		$	419		$	2,156		$	348
	Interest cost on the projected benefit obligation		1,728			768			1,565			768			3,456			1,523			3,130			1,536
	Expected return on plan assets		(2,433	)		(913	)		(2,005	)		(1,283	)		(4,866	)		(1,811	)		(4,010	)		(2,566	)
	Amortization of prior service cost		-			-			23			-			-			-			46			-
	Amortization of net loss		-			-			505			135			-			-			1,010			270
	Net periodic (benefit) cost	$	(705	)	$	66		$	1,166		$	(206	)	$	(1,410	)	$	131		$	2,332		$	(412	)
		For the three months ended June 30,												For the six months ended June 30,
		2014						2013						2014						2013
		(Successor)						(Predecessor)						(Successor)						(Predecessor)
	Postretirement Benefits:	Domestic			Foreign			Domestic			Foreign			Domestic			Foreign			Domestic			Foreign
	Net periodic cost (benefit):
	Service cost	$	14		$	7		$	18		$	11		$	28		$	14		$	36		$	22
	Interest cost on the projected benefit obligation		83			8			73			10			166			16			146			20
	Amortization of prior service cost		-			-			(35	)		7			-			-			(70	)		14
	Net periodic cost	$	97		$	15		$	56		$	28		$	194		$	30		$	112		$	56
	No domestic pension service cost was recognized in the Successor Quarterly or Six month Periods, nor will be in future periods, as benefits in the domestic pension plan were frozen in connection with the MacDermid Acquisition.

Note_8_Debt

Note 8 - Debt	6 Months Ended
	Jun. 30, 2014
Debt Disclosure [Abstract]	'
Debt Disclosure [Text Block]	'
	8.  DEBT
	The Company’s debt consisted of the following:
		30-Jun-14			31-Dec-13
	Borrowings under lines of credit	$	-		$	-
	First lien secured credit facility, due 2020, interest at the greater of 4.00% or LIBOR plus 3.00%, weighted average interest rate of 4.00% at June 30, 2014		747,450			751,225
	Other		1,000			1,024
	Total debt		748,450			752,249
	Less: current portion debt		(7,953	)		(7,958	)
	Total long-term debt	$	740,497		$	744,291
	Predecessor Recapitalization and Refinancing
	On April 12, 2007, the Predecessor closed three senior secured credit facilities consisting of (i) a $360,000 tranche B term loan credit facility denominated in U.S. Dollars (“tranche B”), (ii) a $250,000 tranche C term loan credit facility denominated in Euros (“tranche C”) and (iii) a $50,000 revolving credit facility denominated in U.S. Dollars.
	On June 7, 2013, the Predecessor completed a refinancing arrangement whereby the outstanding tranche B term loan, tranche C term loan, revolving credit facility and senior subordinated notes payable were replaced with two new senior secured credit facilities (the “Refinancing”).  These senior secured credit facilities consisted of (i) a $805,000 first lien credit facility allocated between a $755,000 term loan denominated in U.S. Dollars (“first lien term loan”), a $25,000 revolving credit facility denominated in U.S. Dollars and $25,000 multi-currency revolving credit facility and (ii) a $360,000 second lien term loan credit facility denominated in U.S. Dollars (“second lien term loan”).  The first lien term loan and related revolving credit facilities accrued interest at the greatest of 4.00% or LIBOR plus 3.00% and had quarterly principal payments of $1,878.  The revolving credit facility portion of the first lien term loan was scheduled to mature June 7, 2018.  The first lien term loan was scheduled to mature June 7, 2020.  The second lien term loan accrued interest at the greater of 7.75% or LIBOR plus 6.75% and was scheduled to mature on December 7, 2020.  The first lien and second lien term loans were originally issued at discounts of $1,887 and $3,600, respectively.  These senior secured credit facilities were guaranteed by MacDermid Holdings and certain of its direct and indirect wholly owned domestic subsidiaries and were secured by the personal property owned or hereafter acquired of MacDermid Holdings and certain of its direct and indirect wholly owned domestic subsidiaries and also 65% of the stock of MacDermid Holdings’ first tier foreign subsidiaries, subject to customary exceptions, exclusions and release mechanisms.
	The recapitalization and refinancing transactions sources and uses of cash are summarized below:
	Sources:
	First lien term loan	$	755,000
	Second lien term loan		360,000
	Cash		117,080
	Total sources	$	1,232,080
	Uses:
	Retire Tranche B and Tranche C term loans and accrued interest	$	345,426
	Retire senior subordinated notes, accrued interest and call premium		368,164
	Redemption of Series A preferred stock and accumulated dividends		500,000
	Fees and expenses		13,003
	Discount on first lien term loan and second lien term loan		5,487
	Total uses	$	1,232,080
	As part of the Refinancing, $100,481 of the senior subordinated notes were called but not tendered on June 7, 2013 and were still outstanding on June 30, 2013.  As a result, $105,864 of the new debt proceeds from the refinance and recapitalization were escrowed to pay the outstanding called senior subordinated notes of $100,481, redemption premium of $3,182 and accrued interest $2,201 through the tender date of July 8, 2013. The escrowed funds were paid to the holders of the remaining senior subordinated note holders on July 8, 2013.
	MacDermid utilized $500,000 of the proceeds from the new term loans to complete a recapitalization whereby the outstanding 9.00% cumulative Series A preferred shares and related accumulated payment in kind dividends were exchanged for cash and issuance of cumulative 9.50% cumulative Series B preferred shares.  As a result, 44,977 shares of 9.50% cumulative Series B preferred stock were issued as part of the exchange, the 9.00% cumulative Series A preferred shares were retired and related accumulated payment in kind dividends were paid.
	During the Predecessor Quarterly Period and in connection with the recapitalization and refinancing, MacDermid recorded a loss of $18,788 on extinguishment of debt. This consisted of $12,539 of called bond retirement premiums and $6,249 of write-offs of deferred financing fees related to the extinguished debt.
	In connection with the recapitalization and Refinancing, the Company recorded an additional $13,003 of deferred financing costs during the Predecessor Quarterly Period, which were to be amortized into interest expense over seven years.
	Successor Refinancing
	In connection with the MacDermid Acquisition, on October 31, 2013, MacDermid amended its existing credit agreement dated as of June 7, 2013 (as amended, restated and/or otherwise modified on October 31, 2013 and from time to time, the “Amended and Restated Credit Agreement”) and paid $373,000, including $13,000 in early termination fees and accrued and unpaid interest in connection with the repayment of the $360,000 in principal on its second lien credit facility. Pursuant to the Amended and Restated Credit Agreement, Platform became a co-borrower on all obligations under the $50,000 Revolving Credit Facility and the term loan (together, the “First Lien Facilities”) and the negative and affirmative covenants contained therein were modified to reflect the new corporate structure; otherwise, the terms relating to the incremental facility, maturity, indicative margin, LIBOR floor, ranking, guarantors, mandatory prepayments and financial covenants remained unmodified by the amendment. In connection with the MacDermid Acquisition, the First Lien Credit Facilities were marked to fair value by adding the original discount of $1,775 to the carrying value at the time as the fair value was approximately par.
	In connection with the Chemtura Acquisition as discussed in Note 2 – “Acquisitions of Businesses”, on April 16, 2014, Platform entered into a commitment letter (the “Debt Commitment Letter”) with Barclays Bank PLC for (i) $600,000 of incremental first lien term loans (the “2014 First Lien Facility”) to be incurred under the Amended and Restated Credit Agreement and (ii) second lien term loans (the “2014 Second Lien Facility”) in an aggregate principal amount of $120,000 for the purposes of financing the Chemtura Acquisition and the fees and expenses in connection therewith, on the terms and subject to the conditions set forth in the Debt Commitment Letter. On July 15, 2014, Platform entered into an amended and restated Debt Commitment Letter whereby the maximum commitment under the 2014 First Lien Facility was reduced to $405,000 and the 2014 Second Lien Facility commitment was eliminated. These amendments resulted from Platform’s improved cash on hand position, primarily as a result of the Private Placement completed on May 21, 2014. Unless agreed otherwise, the First Lien Facility will mature on June 7, 2020 respectively.
	During the Successor Quarterly Period, principal and interest payments of $1,888 and $7,577, respectively, were made on the first lien term loan. During the Successor Six Month Period, principal and interest payments of $3,775 and $15,089, respectively, were made on the first lien term loan.  During the Predecessor Quarterly and Six Month Periods, interest payments of $1,762 were made on the first lien term loan.  During the Predecessor Quarterly and Six Month Periods, interest payments of $1,628 were made on the second lien term loan.
	The Company also has letters of credit outstanding of $989 at June 30, 2014.  As indicated above, letters of credit reduce the borrowings available under the Revolving Credit Facility.
	Debt Covenants
	The senior secured credit facilities contain various covenants including restrictions on liens, limitations on additional indebtedness, dividends and other distributions, entry into new lines of business, transactions with affiliates, use of loan proceeds, capital expenditures, restricted payments, amendments to organizational documents, accounting changes, sale and leaseback transactions and dispositions. In addition, the new revolving credit facilities requires the Company to comply with certain financial covenants, including a maximum consolidated leverage ratio, a minimum interest coverage ratio and limitations on capital expenditures if the Company’s funding under the revolving credit facility exceeds $12,500 at the end of the fiscal quarter. As of June 30, 2014, the Company was in compliance with the debt covenants contained in the new senior secured credit facilities.
	Other Debt Facilities
	The Company carries various short-term debt facilities worldwide which are used to fund short-term cash needs.  As of June 30, 2014 and December 31, 2013, there were no borrowings under these other debt facilities.  The Company also has various overdraft facilities available.  At June 30, 2014 and December 31, 2013, the capacity under these overdraft facilities was approximately $23,028 and $22,075, respectively.  As of June 30, 2014, the Company’s overdraft lines bore interest rates ranging from 1% to 6.25%.
	Predecessor Retired Senior Secured Credit Facility
	In addition to scheduled repayments, the tranche B and tranche C loans contained mandatory prepayment provisions, whereby the Company was required to reduce the outstanding principal amounts of these loans based on excess cash flow (as defined in the credit agreement for the tranche B and tranche C loans) as of the most recent completed fiscal year. During the Predecessor Six Month Period, the Predecessor made a mandatory excess cash flow prepayment, based upon 2012 operating results, of $10,277 on the tranche B term loan and $6,810 on the tranche C term loan.
	During the Predecessor Quarterly and Six Month Periods, the outstanding tranche B loan and tranche C loan were retired with payments of $206,479 and $138,737, respectively.
	During the Predecessor Quarterly Period, the Company recorded $7,084 of other expense related to the remeasurement loss on the foreign currency denominated tranche C term loan. During the Predecessor Quarterly Period, the realized portion of the remeasurement gain on the foreign currency denominated tranche C term loan was approximately $4,074.
	During the Predecessor Six Month Period, the Company recorded $3,261 of other expense related to the remeasurement loss on the foreign denominated tranche C term loan. During the Predecessor Six Month Period, the realized portion of the remeasurement gain on the foreign denominated tranche C term loan was approximately $4,398.
	Predecessor Retired Revolving Credit Facility
	There were no balances outstanding under the revolving credit facility on the retirement date.
	Predecessor Senior Subordinated Notes
	As part of the Refinancing, the senior subordinated notes were called on June 7, 2013 and $249,519 of principal and a redemption premium of $9,357 were paid to retire the tendered senior subordinated notes.  Additionally, $105,864 of the new debt proceeds from the refinance and recapitalization were escrowed to pay the outstanding called senior subordinated notes of $100,481. Additionally, proceeds from the refinancing were escrowed for a redemption premium of $3,182 and accrued interest of $2,201 related to these called senior subordinated notes.  The escrowed funds were paid to the holders of the remaining senior subordinated note holders on July 8, 2013.
	Japanese Senior Secured Bank Debt
	In February 2007, the Predecessor borrowed approximately $15,000 denominated in Japanese Yen in three separate notes that were paid in full by their respective maturity dates between 2009 and 2013. In September 2007, the Predecessor borrowed an additional $2,519 denominated in Japanese Yen which was paid in full in July 2013. In October 2009, the Predecessor borrowed $5,569 denominated in Japanese Yen which was paid in full in October 2013.

Note_9_Derivative_Instruments

Note 9 - Derivative Instruments	6 Months Ended
	Jun. 30, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Derivative Instruments and Hedging Activities Disclosure [Text Block]	'
	9. DERIVATIVE INSTRUMENTS
	In the normal course of business, the Company is exposed to risks relating to changes in foreign currency exchange rates, interest rates and commodity prices. Derivative financial instruments, such as foreign currency exchange rate hedges are used to manage changes in market conditions related to foreign currency exchange rate volatility. All derivatives are recognized on the consolidated balance sheets at fair value at the end of each period. The counterparty to the Company’s derivative agreements is a major international financial institution. The Company continually monitors its positions and the credit ratings of its counterparties, and does not anticipate nonperformance by the counterparties.
	Foreign Currency
	The Company conducts a significant portion of its business in currencies other than the U.S. Dollar, the currency in which the Company’s consolidated financial statements are reported, and as a result, the Company’s operating results are affected by foreign currency exchange rate volatility relative to the U.S. dollar. The Company’s Autotype subsidiary in the United Kingdom uses the British Pound Sterling (“GBP”) as its functional currency while approximately 25 percent of its revenues are denominated in U.S. Dollars. In order to protect against the risk of a strengthening GBP, the Company’s corporate treasury group entered into forward contracts in 2013, on behalf of the Autotype subsidiary to deliver U.S. Dollars at a fixed GBP rate and to receive GBP in exchange for the U.S. Dollar. As of June 30, 2014, the aggregate U.S. Dollar notional amount of foreign currency forward contracts, designated as hedges, was $0 as the hedge expired on that date. The Company uses the discounted period-end forward rates methodology to determine market value of its forward contracts.
	During the Successor Quarterly Period, $178 was recorded as unrealized gains to other comprehensive income related to foreign currency hedges. During the Successor Quarterly Period, the Company recorded a realized gain of $315 in other income related to the settlement of hedged foreign exchange contracts.
	During the Successor Six Month Period, $163 was recorded as unrealized losses to other comprehensive income related to hedged foreign currency exchange contracts.  During the Successor Six Month Period, the Company recorded realized gains of $474 in other income related to the settlement of hedged foreign exchange contracts.
	During the Predecessor Quarterly Period, $130 was recorded as unrealized gains to other comprehensive income related to foreign currency hedges. During the Predecessor Quarterly Period, the Company recorded realized (loss) of $(111) in other expense related to the settlement of hedged foreign exchange contracts.
	During the Predecessor Six Month Period, $(650) was recorded as unrealized losses to other comprehensive income related to hedged foreign currency exchange contracts.  During the Predecessor Six Month Period, the Company recorded realized (loss) of $(334) in other expense related to the settlement of hedged foreign exchange contracts.
	The following table summarizes the fair value of derivative instruments reported in the Condensed Consolidated Balance Sheets:
			30-Jun-14		31-Dec-13
			U.S. Dollar Amount		U.S. Dollar Amount
	Derivatives designated as hedging instruments:	Assets Balance Sheet Location
	Foreign exchange contracts	Other current assets	$	-	$	163
	Total derivative contracts		$	-	$	163

Note_10_Fair_Value_Measurement

Note 10 - Fair Value Measurements	6 Months Ended
	Jun. 30, 2014
Fair Value Disclosures [Abstract]	'
Fair Value Disclosures [Text Block]	'
	10. FAIR VALUE MEASUREMENTS
	The Company determines fair value measurements used in its consolidated financial statements based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants exclusive of any transaction costs, as determined by either the principal market or the most advantageous market. The principal market is the market with the greatest level of activity and volume for the asset or liability. Absent a principal market to measure fair value, the Company has used the most advantageous market, which is the market in which the Company would receive the highest selling price for the asset or pay the lowest price to settle the liability, after considering transaction costs. However, when using the most advantageous market, transaction costs are only considered to determine which market is the most advantageous and these costs are then excluded when applying a fair value measurement.
	Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy. The basis for fair value measurements for each level within the hierarchy is described below with Level 1 having the highest priority and Level 3 having the lowest.
	The three levels of the fair value hierarchy are as follows:
	·	Level 1 – quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.
	·	Level 2 – quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in non-active markets; and model derived valuations whose inputs are observable or whose significant valuation drivers are observable.
	·	Level 3 – significant inputs to the valuation model are unobservable and/or reflect the Company’s market assumptions.
	The following tables present the Company’s financial instruments, assets and liabilities that are measured at fair value on a recurring basis:
					Fair Value Measurement Using
			30-Jun-14		Quoted prices in		Significant		Significant
					active markets		other observable		unobservable
					(Level 1)		inputs (Level 2)		inputs (Level 3)
	Asset Category
	Money market accounts		$	56,767	$	56,767	$	-	$	-
	Available for sale equity securities			2,315		1,507		808		-
	Total		$	59,082	$	58,274	$	808	$	-
	Liability Category
	Long term contingent consideration		$	58,600	$	-	$	-	$	58,600
					Fair Value Measurement Using
			31-Dec-13		Quoted prices in		Significant		Significant
					active markets		other observable		unobservable
					(Level 1)		inputs (Level 2)		inputs (Level 3)
	Asset Category
	Money market accounts		$	78,633	$	78,633	$	-	$	-
	Available for sale equity securities			2,302		1,470		832		-
	Derivatives			163		-		163		-
	Total		$	81,098	$	80,103	$	995	$	-
	Liability Category
	Long term contingent consideration		$	34,800	$	-	$	-	$	34,800
	Money market accounts are included in cash and cash equivalents in the Condensed Consolidated Balance Sheets.  Available for sale equity securities are included in other long term assets in the Condensed Consolidated Balance Sheets.
	As discussed in Note 2 - "Acquisitions of Businesses", the long term contingent consideration represents a potential liability up to $100,000 tied to achievement of EBITDA and stock trading price performance metrics over a seven year period in connection with the MacDermid Acquisition. The fair value of the long term contingent consideration was derived using the income approach with unobservable inputs, which included 1) future forecasts and present value assumptions for the EBITDA component and 2) the fair value of Common Stock and related volatility using a Monte Carlo simulation for the Share Price component and there was little or no market data associated with either component. The Company assessed the fair values of the liabilities as of date of the MacDermid Acquisition date and will assess quarterly thereafter until settlement in December 2020.
	Nonrecurring Fair Value Measurements
	The following table presents the carrying value and estimated fair value of the Company’s first lien credit facility:
			30-Jun-14				31-Dec-13
			Carrying		Fair Value		Carrying		Fair Value
			Value				Value
	First lien credit facility, including current portion		$	747,450	$	747,450	$	751,225	$	752,637
	In accordance with the provisions of FASB ASC Topic 350, “Intangibles – Goodwill and Other” other intangible assets with carrying amounts of $4,300 in the Graphic Solutions segment were written down to their implied fair values of $3,900 using Level 3 inputs, resulting in intangible asset impairment charges of $400. These impairment charges were included in selling, technical, general and administrative expense in the accompanying Condensed Consolidated Statements of Operations for the Predecessor Quarterly and Six Month Periods.
	The following methods and assumptions were used to estimate the fair value of each class of the Company’s financial instruments, assets and liabilities:
	Money market accounts - The Company invests in various money market funds which are managed by financial institutions. These money market funds are not publicly traded, but historically have been highly liquid. The fair value of the money market accounts is determined by the banks based upon the funds’ net asset values (“NAV”). All of the money market accounts currently permit daily investments and redemptions at $1.00 NAV.
	Available for sale equity securities - Equity securities classified as available for sale are measured using quoted market prices at the reporting date multiplied by the quantity held. Level II equity securities are measured using quoted prices for similar instruments in active markets.
	Derivatives - The fair values of foreign currency derivatives were determined using pricing models based upon observable market inputs including both forward and spot prices for the underlying currencies.
	First Lien credit facility– The first lien credit facility is measured using quoted market prices at the reporting date multiplied by the carrying amount of the related debt. Such instruments are valued using Level 2 inputs.

Note_11_Stockholders_Equity

Note 11 - Stockholders' Equity	6 Months Ended
	Jun. 30, 2014
Stockholders' Equity Note [Abstract]	'
Stockholders' Equity Note Disclosure [Text Block]	'
	11.  STOCKHOLDERS’ EQUITY
	Successor
	Amendment to Certificate of Incorporation
	On June 12, 2014, the Company amended its Certificate of Incorporation to increase the number of authorized shares of the Company’s Common Stock from two hundred million (200,000,000) to four hundred million (400,000,000) shares of Common Stock.
	Founder Preferred Shares
	On April 25, 2013, the Company issued one preferred share each to Mariposa Acquisition, LLC and Berggruen Acquisition Holdings, IV, Ltd, our founder entities (collectively, the “Founders”), for $20.00. In connection with the initial public offering on May 22, 2013, the Founders purchased an additional 1,999,998 preferred shares (“Preferred” shares or stock; $0.01 par value) for $20,000. The preferred shares have certain voting rights.  Beginning in 2014, the holders of the Preferred stock are entitled to receive a dividend in the form of shares of Common Stock equal to 20% of the appreciation of the market price of common shares multiplied by total initial offering shares (90,500,000 shares). In the first year a dividend is payable (if any), the dividend amount will be calculated at the calendar year-end based on the last ten trading days volume weighted average share price (the “Dividend Price) compared to the initial offering price of $10.00 per ordinary share. In subsequent years, the dividend amount will be calculated based on the appreciated stock price compared to the highest Dividend Price previously used in calculating the Preferred stock dividends. Dividends are paid for the term the Preferred stock is outstanding. The Preferred shares may be converted into ordinary shares on a one for one basis (i) automatically in the event of a change of control of the Company following an acquisition, (ii) upon the last day of the seventh full financial year following the MacDermid Acquisition (December 31, 2020, (extendable by the Board of Directors for three additional years)), or (iii) at the option of the holder until December 31, 2020.  No shares were issued or dividends paid in the Successor Quarterly or Six Month Period. Although not finally determinable until December 31, 2014, had the closing price for the Company’s Common Stock on June 30, 2014 been used, a dividend of approximately 11.3 million shares would have been issued to the Founders.
	Common Shares
	In connection with the initial public offering on May 22, 2013, the Company issued 88,500,000 common shares (no par value) for gross proceeds of $885,000. Also, on May 22, 2013, the Company issued an aggregate of 29,500 common shares to non-founder directors for $10.00 per share. Each common share has voting rights and winding-up rights.
	Each of the 2,000,000 Preferred shares, 88,500,000 common shares issued in connection with the initial public offering as well as the 29,500 common shares issued to the non-founder directors was issued with a warrant (90,529,500 warrants in aggregate), entitling the holder of each warrant to purchase one-third of common shares with a strike price of $11.50 per common share. Each warrant was exercisable until three years from the date of an acquisition, unless mandatorily redeemed by the Company. The warrants were mandatorily redeemable by the Company at a price of $0.01 should the average market price of a common share exceed $18.00 for 10 consecutive trading days.  In order to fund a portion of the cash consideration for the MacDermid Acquisition in November 2013, the Company conducted an offer to issue shares of Common Stock of the Company in exchange for $10.50 and 3 warrants, up to a maximum of half of the warrants outstanding (the Warrant Exchange Offer”) in which 40,386,840 warrants (representing $141,354 in cash) were exercised and 13,462,280 underlying shares of Common Stock were issued.  In conjunction with the Warrant Exchange Offer not being fully subscribed, on November 13, 2013, the Company issued 380,952 shares at $10.50 per share to the Founders and issued 190,476 shares each to two of its independent directors at $10.50 per share.
	In connection with the MacDermid Acquisition, the Company agreed to apply to list its shares on the NYSE and to change its jurisdiction of incorporation from the British Virgin Islands to Delaware, (the “Domestication”).  The Company filed a registration statement on Form S-4 with the SEC to effect these changes.  The registration statement was declared effective on January 22, 2014 and on that same date the Company completed its Domestication. On January 23, 2014, the Company’s Common Stock began trading on the NYSE under the ticker symbol “PAH.” On March 4, 2014, pursuant to the terms of an Exchange Agreement, dated October 25, 2013, between the Company and the fiduciaries of the MacDermid Savings Plan, the Company acquired the remaining approximately 3% of the MacDermid Plan Shares for approximately $2,600 in cash (which is reflected in “Acquisition of business, net” in the accompanying Condensed Consolidated Statements of Cash Flows) and 1,670,386 shares of the Company’s Common Stock.
	In connection with the Domestication, (i) each ordinary share of the Company that was issued and outstanding immediately prior to the Domestication was automatically converted into one share of Common Stock (par value $0.01) of the Company, (ii) outstanding options, warrants and other rights to acquire ordinary shares became options, warrants or rights to acquire the corresponding shares of Common Stock of the Company, and (iii)  each Founder Preferred share that was issued and outstanding immediately prior to the Domestication was automatically converted into one share of Series A Preferred Stock of the Company.
	On March 4, 2014, a mandatory redemption event occurred with respect to all of the Company’s outstanding warrants. The Company fixed April 3, 2014 as the date of the mandatory redemption of the warrants, and accordingly, on or after that date, holders of warrants had no further rights with regard to such warrants except to receive $0.01 per warrant. During the Successor Quarterly Period, 3,755,232 warrants were exercised for 1,251,744 shares of Common Stock resulting in proceeds to the Company of $14,395. During the Successor Six Month Period, the Company issued 16,244,694 shares of Common Stock in connection with the exercise of a total of 48,734,082 warrants resulting in proceeds to the Company of $186,814. On April 3, 2014, Platform completed the mandatory redemption of the remaining 8,580 outstanding warrants for $0.01 per warrant.
	On May 20, 2014, the Company issued to certain investors, an aggregate of 15,800,000 shares of the Company’s Common Stock for an aggregate consideration of $300,200, gross of transaction costs of approximately $13,433, through the Private Placement. Such shares were not registered under the Securities Act of 1933, as amended (the “Securities Act”) and were issued pursuant to an exemption from registration provided under Section 4(a)(2) of the Securities Act.  On May 23, 2014, we filed a resale registration statement on Form S-1, which registered an aggregate of 14,825,000 shares of the Company’s Common Stock acquired in the Private Placement. Such registration statement, as amended on June 13, 2014, was declared effective on June 19, 2014 and the 14,825,000 shares covered by such registration statement were eligible for resale in the public market immediately after the effective date of such registration statement.
	Non-Controlling Interest
	As described more fully in Note 2 – “Acquisitions of Businesses”, in connection with the MacDermid Acquisition, certain sellers elected to receive shares of common stock of Platform’s subsidiary PDH (the “PDH Common Stock”) representing approximately $97,500, which is classified as a non-controlling interest on the Condensed Consolidated Balance Sheets at June 30, 2014 and December 31, 2013 and will continue to be until such time as it is exchanged for Platform’s Common Stock. Approximately $1,314 and $3,068 of net income has been allocated to the non-controlling interest for the three and six months ended June 30, 2014, respectively, and is included in the accompanying Condensed Consolidated Statements of Operations.
	A reconciliation of consolidated changes in equity for the Successor Six Month Period, the Platform Preacquisition Period and the Predecessor Six Month Period is as follows:
	Successor
		Preferred Stock							Common Stock
		Shares			Amount				Shares				Amount				Additional			Accumulated			Accumulated			Total			Non-			Total equity
																	Paid-in			Deficit			other comprehensive income (loss)			Stockholders'			controlling
																	Capital									Equity			interest
	Balance at December 31, 2013		2,000,000		$	-				103,571,941			$	-			$	1,212,038		$	(194,222	)	$	1,265		$	1,019,081		$	96,021		$	1,115,102
	Impact of Domestication		-			20				-				1,016				(1,036	)		-			-			-			-			-
	Issuance of common shares @ $11.00 per share on January 5, 2014		-			-				3,959				-				44			-			-			44			-			44
	Exercise of warrants for common shares @ $11.50 per share		-			-				16,244,694				163				186,652			-			-			186,815			-			186,815
	Issuance of common shares @$19.00 per share in connection with Private Placement Offering									15,800,000				158				300,042			-			-			300,200			-			300,200
	Issuance costs in connection with Private Placement Offering		-			-				-				-				(13,433	)		-			-			(13,433	)		-			(13,433	)
	Issuance of common shares @$11.00 per share in connection with 401(k) Exchange Agreement		-			-				1,670,386				16				18,358			-			-			18,374			-			18,374
	Recovery of short swing profits, net		-			-				-				-				515			-			-			515			-			515
	Equity compensation expense		-			-				-				-				303			-			-			303			-			303
	Net (loss) income		-			-				-				-				-			(7,794	)		-			(7,794	)		3,334			(4,460	)
	Foreign currency translation adjustments		-			-				-				-				-			-			22,975			22,975			14			22,989
	Pension and postretirement plans, tax benefit of $11		-			-				-				-				-			-			228			228			-			228
	Derivatives valuation, net of tax benefit of $63		-			-				-				-				-			-			(100	)		(100	)		-			(100	)
	Unrealized gain on available for sale equity securities, net of tax provision of $2		-			-				-				-				-			-			4			4			-			4
	Distribution to non-controlling interest		-			-				-				-				-			-			-			-			(380	)		(380	)
	Balance at June 30, 2014		2,000,000		$	20				137,290,980			$	1,353			$	1,703,483		$	(202,016	)	$	24,372		$	1,527,212		$	98,989		$	1,626,201
	Successor
		Preferred Stock							Common Stock
		Shares			Amount				Shares				Amount				Additional			Accumulated			Total
																	Paid-in			Deficit			Stockholders'
																	Capital						Equity
	Balance at April 23, 2013 (Inception)		-		$	-				-			$	-			$	-		$	-		$	-
	Issuance of preferred shares @ $10.00 per share on April 25, 2013		2			-				-				-				-			-			-
	Issuance of preferred shares @ $10.00 per share with matching warrants on May 22, 2013 along with 2 matching warrants matching with previously issued preferred shares		1,999,998			-				-				-				20,000			-			20,000
	Issuance of common shares @ $10.00 per share with matching warrants on May 22, 2013		-			-				88,529,500				-				885,296			-			885,296
	Equity offering cost		-			-				-				-				(24,078	)		-			(24,078	)
	Equity compensation expense		-			-				-				-				49			-			49
	Net loss		-			-				-				-				-			(80	)		(80	)
	Balance at June 30, 2013		2,000,000		$	-				88,529,500			$	-			$	881,267		$	(80	)	$	881,187
	Predecessor
		Series A			Series B				Common				Additional				Accumulated			Accumulated			Treasury			Total			Non-			Total equity
		Preferred			Preferred				Shares				Paid-In				deficit			other comprehensive			Stock			Stockholders'			controlling			(deficit)
		Shares			Shares								Capital							income (loss)						Equity			interest
	Balance at December 31, 2012	$	525,027		$	-			$	50,000			$	2,318			$	(273,086	)	$	(30,270	)	$	(1,264	)	$	272,725		$	(288	)	$	272,437
	Net income		-			-				-				-				9,393			-			-			9,393			180			9,573
	Equity compensation		-			-				-				78				-			-			-			78			-			78
	Accrual of paid in kind dividend on cumulative preferred shares		20,805			267				-				-				(21,072	)		-			-			-			-			-
	Foreign currency translation adjustments		-			-				-				-				-			(22,009	)		-			(22,009	)		(32	)		(22,041	)
	Derivatives valuation, net of tax  benefit of $227		-			-				-				-				-			(423	)		-			(423	)		-			(423	)
	Unrealized loss on available for sale equity securities, net of tax expense of $17		-			-				-				-				-			32			-			32			-			32
	Shares repurchased		(500,000	)		-				-														(8	)		(500,008	)		-			(500,008	)
	Shares exchanged		(44,977	)		44,977				-																	-			-			-
Shares canceled		(855	)		-				(417	)													1,272			-			-			-
Dividend paid to non-controlling interest partner		-			-				-				-				-			-			-			-			(304	)		(304	)
Contribution from non-controlling interest		-			-				-				-				-			-			-			-			17			17
Balance at June 30, 2013	$	-		$	45,244			$	49,583			$	2,396			$	(284,765	)	$	(52,670	)	$	-		$	(240,212	)	$	(427	)	$	(240,639	)
The income tax benefit (provision) allocated to the components of other comprehensive income for the Successor and Predecessor Quarterly and Six Month Periods is as follows:
	For the three months ended June 30,								For the six months ended June 30,
	2014				2013				2014					2013
	(Successor)				(Predecessor)				(Successor)					(Predecessor)
Foreign currency translation adjustment	$	-			$	-			$	-				$	-
Unrealized gain loss on available for sale securities		(20	)			33				(2	)				(17	)
Pension and postretirement plans		-				-				11					-
Derivative valuation		73				(45	)			63					227
Income tax benefit (provision) related to other comprehensive income	$	53			$	(12	)		$	72				$	210

Note_12_Earnings_Per_Share

Note 12 - Earnings Per Share	6 Months Ended
	Jun. 30, 2014
Earnings Per Share [Abstract]	'
Earnings Per Share [Text Block]	'
	12.  EARNINGS PER SHARE
	A computation of the weighted average shares outstanding for the Successor Quarterly and Six Month Periods and Platform Preacquisition Period follows.
	(in thousands)	Three months ended			Period from			Six months ended			Period from
		30-Jun-14			Inception			30-Jun-14			Inception
					(April 23, 2013)						(April 23, 2013)
					through June 30, 2013						through June 30, 2013
	Net income attributable to common shareholders	$	(376	)	$	(80	)	$	(7,794	)	$	(80	)
	Basic weighted average common shares outstanding		128,595			88,529			117,937			88,529
	Dilutive weighted average common shares outstanding 1		128,595			88,529			117,937			88,529
	1 No share adjustments are included in the dilutive weighted average shares outstanding computation as each period was a net loss.
	The following weighted-average stock options and warrants were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive (in thousands).
		Three months ended			Six months ended
		30-Jun-14			30-Jun-14
	Number of shares contingently issuable for founder preferred share dividend rights		11,279			11,279
	Number of shares issuable upon conversion of the PDH non-controlling interest		8,775			8,775
	Number of shares issuable upon conversion of founder preferred shares		2,000			2,000
	Number of shares contingently issuable for the contingent consideration		713			713
	Number of warrants		-			2,243
	Number of shares issuable upon conversion of the 401k exchange rights		-			544
	Number of stock options		88			80
	Number of restricted stock shares and units		2			1
			22,857			25,635

Note_13_Contingencies_Environm

Note 13 - Contingencies, Environmental and Legal Matters	6 Months Ended
	Jun. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies Disclosure [Text Block]	'
	13. CONTINGENCIES, ENVIRONMENTAL AND LEGAL MATTERS
	Asset Retirement Obligations
	The Company has recognized asset retirement obligations (“AROs”) for properties where it can make a reasonable estimate of the future expenditures necessary to satisfy the related obligations. The Company considers identified legally enforceable obligations, estimated settlement dates and appropriate discount and inflation rates in calculating the fair value of its AROs. At June 30, 2014 and December 31, 2013, the Company has accrued $5,364 and $4,765, respectively, for its AROs at sites in the U.S., Europe and Japan.  The AROs are classified in the accompanying Condensed Consolidated Balance Sheets as of June 30, 2014 and December 31, 2013 as follows:
		30-Jun-14		31-Dec-13
	Accrued expenses and other current liabilities	$	463	$	69
	Other long-term liabilities		4,901		4,696
		$	5,364	$	4,765
	Environmental
	The Company is a manufacturer and distributor of specialty chemical products, and is exposed to claims with respect to environmental cleanup or other matters, including those in connection with the disposal of hazardous materials.  The Company is subject to extensive domestic and foreign laws and regulations relating to environmental protection and worker health and safety, including those governing discharges of pollutants into the air and water, the management and disposal of hazardous substances and wastes, and the cleanup of contaminated properties.  The Company has incurred, and will continue to incur, costs and capital expenditures in complying with these laws and regulations.  Additional costs could be incurred, including cleanup costs, fines, sanctions, and third-party claims, as a result of violations of or liabilities under environmental laws.
	Remediation activities vary substantially in duration and cost from site to site. These activities, and their associated costs, depend on the mix of unique site characteristics, evolving remediation technologies, diverse regulatory agencies and enforcement policies, as well as the presence or absence of potentially responsible parties. The Company has received notices of violation with respect to instances of non-compliance with environmental laws. A number of facilities and former facilities of the Company have been environmentally impacted from historic operations and some facilities are in the process of being investigated and remediated. As of June 30, 2014 and December 31, 2013, $2,250 and $2,896, respectively, was reserved for various environmental matters. Ultimate costs may vary from current estimates, and the discovery of additional contaminants at these facilities or other sites, or the imposition of additional cleanup obligations or third-party claims relating thereto could result in additional costs.  Management believes that any possible losses related to environmental remediation in addition to the amounts recorded as of June 30, 2014 and December 31, 2013 would not be material to the Company’s consolidated financial position, results of operations or cash flows.
	Legal Proceedings
	On July 8, 2014, a federal court jury found in favor of MacDermid Printing Solutions LLC ("MPS") in litigation against Cortron, Inc. (“Cortron”) and awarded MPS $3,941 in anti-trust damages; $7,904 in breach of contract damages; $3,791 and additional punitive damages for misappropriation of trade secrets, and $11,875 plus additional punitive damages for unfair trade practices. The actual aggregate amount of damages, including the amount of punitive damages and an award of attorney fees will be determined by the presiding judge after post-trial briefing by the parties. Cortron may appeal the verdict; accordingly, MPS's ability to collect on the judgment is uncertain.  All proceeds from this litigation are subject to the pending litigation provisions of the Platform Business Combination Agreement as discussed in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2013.
	From time to time, the Company is involved in various legal proceedings in the normal course of its business. Management believes that the resolution of these claims, to the extent not covered by insurance, will not individually or in the aggregate, have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows. As of June 30, 2014 and December 31, 2013, the Company has reserved approximately $3,293 and $2,881, respectively, for its outstanding legal proceedings.

Note_14_Income_Taxes

Note 14 - Income Taxes	6 Months Ended
	Jun. 30, 2014
Income Tax Disclosure [Abstract]	'
Income Tax Disclosure [Text Block]	'
	14. INCOME TAXES
	The tax impact of the year to date fair value adjustment to the long term contingent consideration liability was recorded in the interim periods as a reliable estimate of the full year adjustment could not be reasonably made.  Additionally, unrecognized tax benefits of approximately $7.6 million may be recognized within the next 12 months.
	The Company has historically provided deferred taxes under ASC 740-30-25, formerly APB 23, for the presumed repatriation to the United States earnings from several non-U.S. subsidiaries.  The indefinite reversal criterion of ASC 740-30-25 allows the Company to overcome that presumption to the extent the earnings are indefinitely reinvested outside the United States.
	In June 2014, the Company determined that approximately $23.7 million of certain foreign subsidiaries’ undistributed net earnings would now be indefinitely reinvested in operations outside the United States.  These earnings will provide the Company an opportunity to reinvest in the existing international business and provide funding for future acquisitions outside of the United States.  As a result of the change in assertion, the Company reduced its deferred tax liabilities related to undistributed foreign earnings by $4.5 million as a discrete item in the second quarter.

Note_15_Related_Party_Transact

Note 15 - Related Party Transactions	6 Months Ended
	Jun. 30, 2014
Related Party Transactions [Abstract]	'
Related Party Transactions Disclosure [Text Block]	'
	15.  RELATED PARTY TRANSACTIONS
	Immediately prior to the closing of the MacDermid Acquisition, each Retaining Holder, including certain officers of MacDermid, executed a RHSA with the Company pursuant to which they agreed to exchange their respective interests in MacDermid Holdings for PDH Common Stock of Platform’s subsidiary PDH, at an exchange rate of $11.00 per share plus, with respect to the common, class A and class B unit equity interests of MacDermid Holdings held by the Retaining Holder (i) a proportionate share of a contingent interest in certain pending litigation, and (ii) a proportionate share of up to $100 million of contingent purchase price payable upon the attainment of certain EBITDA and stock trading price performance metrics during the seven-year period following the closing of the MacDermid Acquisition as discussed further in Note 2 – “Acquisitions of Businesses”. Immediately prior to the closing of the MacDermid Acquisition, members of MacDermid management and certain affiliates, including certain officers of MacDermid, contributed all or a portion of their MacDermid Holdings interests to Tartan Holdings, LLC, a newly-formed Delaware limited liability company (“Tartan”), and Tartan agreed to receive the PDH Common Stock in exchange for such MacDermid Holdings equity interests. The resulting noncontrolling interest percentage for the Retaining Holders was 6.76%.
	Pursuant to an Advisory Services Agreement between the Company and Mariposa Capital, LLC, an affiliate of one of our Founders, (“Mariposa”), advisory fees paid to Mariposa, for the Successor Quarterly and Six Month Periods were $500 and $1,000, respectively.
	On November 7, 2013, the Company entered into a registration rights agreement with Pershing Square Capital Management, L.P. (“Pershing Square”), the beneficial owner of approximately 24.3% of the Company’s outstanding shares as of June 30, 2014. Those shares were acquired by Pershing Square in the initial public offering and the Warrant Exchange Offer. Pursuant to the agreement, for so long as any of the included funds managed by Pershing Square holds any Platform shares, the Company agreed to cooperate with such holders’ reasonable requests to facilitate any proposed sale of shares by the requesting holder(s) in accordance with the provisions of Rule 144 or any successor rule (“Rule 144”) promulgated under the Securities Act, including, without limitation, by complying with the current public information requirements of Rule 144 and providing opinions of counsel, to the extent required. Additionally, the Company agreed that promptly after becoming eligible to utilize a Form S-3 registration statement, the Company will file with the SEC a registration statement on Form S-3 registering (among other securities) the resale of the Company shares held by the holders and use its commercially reasonable efforts to have such registration statement declared effective as soon as practicable after its filing. The Company’s obligations under the registration rights agreement shall terminate on the earlier of (i) the date on which all of a holder’s shares have been sold, and (ii) the date on which all of a holder’s shares may be sold pursuant to Rule 144 without volume or other restrictions.
	For the three and six months ended June 30, 2013, the Company paid management fees of $102 and $204, respectively, to Court Square Capital Partners II LP, a Predecessor investor.
	For the three and six months ended June 30, 2013, the Company paid management fees to Weston Presidio, a Predecessor investor, of $23 and $47, respectively.

Note_16_Restructuring_Activiti

Note 16 - Restructuring Activities	6 Months Ended
	Jun. 30, 2014
Restructuring and Related Activities [Abstract]	'
Restructuring and Related Activities Disclosure [Text Block]	'
	16.  RESTRUCTURING ACTIVITIES
	During both the three and six months ended June 30, 2014, the Company recorded $404 of restructuring expense relating to the elimination of certain positions in both the Graphic Solutions and the Performance Materials segments. During the three and six months ended June 30, 2013, the Company recorded $46 and $1,652, respectively, of restructuring expense primarily relating to the elimination of certain positions in both the Graphic Solutions and the Performance Materials segments.  As of June 30, 2014, the Company has accrued restructuring costs of $1,325 that are anticipated to be paid out in the next twelve months.
	Restructuring expense was as follows for the three and six month periods ended June 30, 2014 and 2013:
		For the three months ended June 30,						For the six months ended June 30,
		2014			2013			2014				2013
		(Successor)			(Predecessor)			(Successor)				(Predecessor)
	Severance and other benefits	$	404		$	46		$	404			$	1,652
	Total restructuring expense	$	404		$	46		$	404			$	1,652
	The activity in the restructuring liabilities for the Successor and Predecessor Six Month Periods was as follows:
				For the Successor Period
	Successor	Balance,		Charges to			Cash			Non-cash				Balance,
		December 31,		Expense			Payments			Adjustments				June 30,
		2013												2014
	Graphic Solutions:
	Severance and other benefits	$	699	$	179		$	(291	)	$	-			$	587
	Total Graphics Solutions		699		179			(291	)		-				587
	Performance Materials:
	Severance and other benefits		1,330		225			(741	)		(76	)			738
	Total Performance Materials		1,330		225			(741	)		(76	)			738
	Total restructuring liability	$	2,029	$	404		$	(1,032	)	$	(76	)		$	1,325
				For the Predecessor Period
	Predecessor	Balance,		Charges to			Cash			Non-cash				Balance,
		December 31,		Expense			Payments			Adjustments				June 30,
		2012												2013
	Graphic Solutions:
	Severance and other benefits	$	-	$	1,508		$	(643	)	$	-			$	865
	Total Graphics Solutions		-		1,508			(643	)		-				865
	Performance Materials:
	Severance and other benefits		632		144			(112	)		(9	)			655
	Total Performance Materials		632		144			(112	)		(9	)			655
	Total restructuring liability	$	632	$	1,652		$	(755	)	$	(9	)		$	1,520

Note_17_Segment_Information

Note 17 - Segment Information	6 Months Ended
	Jun. 30, 2014
Segment Reporting [Abstract]	'
Segment Reporting Disclosure [Text Block]	'
	17.  SEGMENT INFORMATION
	The Company’s operations are organized into two reportable segments: Performance Materials and Graphic Solutions.
	The Performance Materials segment manufactures and markets dynamic chemistry solutions that are used in the electronics, automotive and oil and gas production and drilling industries. Its products include surface and coating materials and water-based hydraulic control fluids. In conjunction with the sale of these products, we provide extensive technical service and support to ensure superior performance of their application. Within the Performance Materials segment, the Company has two primary categories of products. Industrial products are materials used to improve the performance or look of a component of an industrial part or process.  Electronic products are materials used to manufacture and improve the performance of circuit boards and similar electronic items.
	The Graphic Solutions segment primarily produces and markets photopolymers through an extensive line of flexographic plates that are used in the commercial packaging and printing industries. The Company evaluates the performance of its segments based on net sales and operating profit. Operating profit for each segment includes net sales to third parties, related cost of sales and operating expenses directly attributable to the segment. Operating profit for each segment includes an allocation of corporate costs such as corporate salary and wages, equity compensation expense and legal costs.
	The following table summarizes financial information regarding each reportable segment’s results of operations for the periods presented:
		For the three months ended June 30,					For the six months ended June 30,
		2014			2013		2014			2013
		(Successor)			(Predecessor)		(Successor)			(Predecessor)
	Net Sales:
	Performance Materials	$	147,129		$	145,274	$	290,240		$	284,098
	Graphic Solutions		42,003			44,718		82,618			88,026
	Consolidated net sales		189,132			189,992		372,858			372,124
	Operating profit (loss):
	Performance Materials		16,641			27,115		25,480			48,563
	Graphic Solutions		(11,035	)		9,517		(15,882	)		17,845
	Consolidated operating profit	$	5,606		$	36,632	$	9,598		$	66,408

Note_18_Subsequent_Events

Note 18 - Subsequent Events	6 Months Ended
	Jun. 30, 2014
Subsequent Events [Abstract]	'
Subsequent Events [Text Block]	'
	18.  SUBSEQUENT EVENTS
	On August 4, 2014, MacDermid Agricultural Solutions Holdings B.V., a limited liability company incorporated and organized under the laws of the Netherlands and a wholly-owned subsidiary of  Platform, as the purchaser (the “Purchaser”), and Platform, as guarantor, entered into an agreement (the “Agreement”) with a representative (the “Vendor”) of Percival S.A., a  société anonyme incorporated and organized under the laws of Belgium (“Percival”), pursuant to which the Purchaser agreed to acquire Percival, including Percival’s agrochemical business that does business under the Agriphar trade name and which product portfolio includes a wide range of herbicide, fungicides and insecticides (the “Agriphar Acquisition”), for €300 million, consisting of €285 million in cash, subject to working capital and other adjustments, and a number of shares of  Common Stock equal to the U.S. Dollar equivalent of €15 million (the “Shares”).
	The Vendor agreed not to transfer the Shares prior to January 2, 2018 without the prior written consent of the Purchaser; it being understood that (i) as of January 2, 2016, the Vendor may freely transfer a maximum of 1/3 of the Shares, and (ii) as of January 2, 2017, the Vendor may freely transfer a maximum of an additional 1/3 of the Shares, subject to the terms and provisions of a solvency letter described in the Agreement. Platform has agreed to guarantee to the Vendor the due and punctual performance and observance by the Purchaser of all its obligations under the Agreement.
	The Agriphar Acquisition is expected to close no later than December 31, 2014, subject to the satisfaction or waiver of certain customary and other closing conditions.

Accounting_Policies_by_Policy_

Accounting Policies, by Policy (Policies)	6 Months Ended
	Jun. 30, 2014
Accounting Policies [Abstract]	'
New Accounting Pronouncements Not Yet Adopted Policy Text Block]	'
	In May 2014, the FASB issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers (Topic 606)” which 1) removes inconsistencies and weaknesses in revenue requirements, 2) provides a more robust framework for addressing revenue issues, 3) improves comparability of revenue recognition practices across entities, industries, jurisdictions, and capital markets, 4) provides more useful information to users of financial statements through improved disclosure requirements and 5) simplifies the preparation of financial statements by reducing the number of requirements to which an entity must refer.  The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2016. The Company is in the process of evaluating the impact of this new ASU.
New Accounting Pronouncements, Policy [Policy Text Block]	'
	In March 2013, the FASB issued ASU No. 2013-05, “Foreign Currency Matters (Topic 830): Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity, (a consensus of the FASB Emerging Issues Task Force)” which resolves diversity in practice regarding the release of the cumulative translation adjustment into net income when a parent either sells a part or all of its investments in a foreign entity. In addition, the standard resolves diversity in practice for the treatment of business combinations achieved in stages involving a foreign entity. The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2013. The adoption of this new ASU did not have a material impact on our consolidated financial position, results of operations or cash flows in the Successor Quarterly or Six Month Periods.

Note_2_Acquisitions_of_Busines1

Note 2 - Acquisitions of Businesses (Tables)	6 Months Ended
	Jun. 30, 2014
Business Combinations [Abstract]	'
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	'
	Purchase Price Allocation (in thousands):	Original			Revised			Revision
	Preliminary value assigned:
	Accounts receivable	$	147,400		$	147,400		$	-
	Inventories		115,300			115,300			-
	Other current assets		26,200			26,200			-
	Property, plant and equipment		142,800			140,900			(1,900	)
	Customer relationships		458,400			494,000			35,600
	Developed technology		155,000			164,200			9,200
	Tradenames		73,400			70,800			(2,600	)
	Goodwill		993,800			990,000			(3,800	)
	Other assets		30,800			28,300			(2,500	)
	Accounts payable		(55,900	)		(55,900	)		-
	Other current liabilities		(62,100	)		(62,000	)		100
	Long-term debt		(754,200	)		(754,200	)		-
	Non-current deferred tax liability		(140,700	)		(171,200	)		(30,500	)
	Contingent consideration		(35,500	)		(35,500	)		-
	Redeemable 401(k) plan interest		(21,000	)		(21,000	)		-
	Other liabilities		(66,500	)		(66,500	)		-
	Total purchase price	$	1,007,200		$	1,010,800		$	3,600

Note_3_Inventories_Tables

Note 3 - Inventories (Tables)	6 Months Ended
	Jun. 30, 2014
Inventory Disclosure [Abstract]	'
Schedule of Inventory, Current [Table Text Block]	'
		30-Jun-14		31-Dec-13
	Finished goods	$	49,880	$	58,360
	Raw materials and supplies		28,761		29,870
	Equipment		1,870		1,388
	Total inventory, net	$	80,511	$	89,618

Note_4_Property_Plant_and_Equi1

Note 4 - Property, Plant and Equipment (Tables)	6 Months Ended
	Jun. 30, 2014
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment [Table Text Block]	'
		30-Jun-14			31-Dec-13
	Land and leasehold improvements	$	27,860		$	29,946
	Buildings and improvements		36,290			38,914
	Machinery, equipment and fixtures		73,424			63,475
			137,574			132,335
	Less: accumulated depreciation		(14,202	)		(3,900	)
			123,372			128,435
	Construction in process		10,269			7,731
	Property, plant and equipment, net	$	133,641		$	136,166

Note_5_Goodwill_and_Intangible1

Note 5 - Goodwill and Intangible Assets (Tables)	6 Months Ended
	Jun. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Schedule of Goodwill [Table Text Block]	'
		Performance		Graphic			Total
		Materials		Solutions
	Balance, December 31, 2013	$	760,371	$	229,437		$	989,808
	Foreign currency translation and other		14,089		457			14,546
	Balance, June 30, 2014	$	774,460	$	229,894		$	1,004,354
Schedule of Finite-Lived Intangible Assets [Table Text Block]	'
		30-Jun-14							31-Dec-13
		Gross Carrying		Accumulated			Net Book		Gross Carrying		Accumulated			Net Book
		Amount		Amortization and			Value		Amount		Amortization and			Value
				Foreign Exchange							Foreign Exchange
	Customer lists	$	494,000	$	(19,600	)	$	474,400	$	494,000	$	(6,420	)	$	487,580
	Developed technology		164,200		(10,190	)		154,010		164,200		(2,391	)		161,809
	Total	$	658,200	$	(29,790	)	$	628,410	$	658,200	$	(8,811	)	$	649,389

Note_7_Pension_PostRetirement_1

Note 7 - Pension, Post-Retirement and Post-Employment Plans (Tables)	6 Months Ended
	Jun. 30, 2014
Compensation and Retirement Disclosure [Abstract]	'
Schedule of Net Benefit Costs [Table Text Block]	'
		For the three months ended June 30,												For the six months ended June 30,
		2014						2013						2014						2013
		(Successor)						(Predecessor)						(Successor)						(Predecessor)
	Pension & SERP Benefits:	Domestic			Foreign			Domestic			Foreign			Domestic			Foreign			Domestic			Foreign
	Net periodic cost (benefit):
	Service cost	$	-		$	211		$	1,078		$	174		$	-		$	419		$	2,156		$	348
	Interest cost on the projected benefit obligation		1,728			768			1,565			768			3,456			1,523			3,130			1,536
	Expected return on plan assets		(2,433	)		(913	)		(2,005	)		(1,283	)		(4,866	)		(1,811	)		(4,010	)		(2,566	)
	Amortization of prior service cost		-			-			23			-			-			-			46			-
	Amortization of net loss		-			-			505			135			-			-			1,010			270
	Net periodic (benefit) cost	$	(705	)	$	66		$	1,166		$	(206	)	$	(1,410	)	$	131		$	2,332		$	(412	)
		For the three months ended June 30,												For the six months ended June 30,
		2014						2013						2014						2013
		(Successor)						(Predecessor)						(Successor)						(Predecessor)
	Postretirement Benefits:	Domestic			Foreign			Domestic			Foreign			Domestic			Foreign			Domestic			Foreign
	Net periodic cost (benefit):
	Service cost	$	14		$	7		$	18		$	11		$	28		$	14		$	36		$	22
	Interest cost on the projected benefit obligation		83			8			73			10			166			16			146			20
	Amortization of prior service cost		-			-			(35	)		7			-			-			(70	)		14
	Net periodic cost	$	97		$	15		$	56		$	28		$	194		$	30		$	112		$	56

Note_8_Debt_Tables

Note 8 - Debt (Tables)	6 Months Ended
	Jun. 30, 2014
Debt Disclosure [Abstract]	'
Schedule of Debt [Table Text Block]	'
		30-Jun-14			31-Dec-13
	Borrowings under lines of credit	$	-		$	-
	First lien secured credit facility, due 2020, interest at the greater of 4.00% or LIBOR plus 3.00%, weighted average interest rate of 4.00% at June 30, 2014		747,450			751,225
	Other		1,000			1,024
	Total debt		748,450			752,249
	Less: current portion debt		(7,953	)		(7,958	)
	Total long-term debt	$	740,497		$	744,291
Recapitalization and Refinancing Transactions Sources and Uses of Cash [Table Text Block]	'
	Sources:
	First lien term loan	$	755,000
	Second lien term loan		360,000
	Cash		117,080
	Total sources	$	1,232,080
	Uses:
	Retire Tranche B and Tranche C term loans and accrued interest	$	345,426
	Retire senior subordinated notes, accrued interest and call premium		368,164
	Redemption of Series A preferred stock and accumulated dividends		500,000
	Fees and expenses		13,003
	Discount on first lien term loan and second lien term loan		5,487
	Total uses	$	1,232,080

Note_9_Derivative_Instruments_

Note 9 - Derivative Instruments (Tables)	6 Months Ended
	Jun. 30, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]	'
			30-Jun-14		31-Dec-13
			U.S. Dollar Amount		U.S. Dollar Amount
	Derivatives designated as hedging instruments:	Assets Balance Sheet Location
	Foreign exchange contracts	Other current assets	$	-	$	163
	Total derivative contracts		$	-	$	163

Note_10_Fair_Value_Measurement1

Note 10 - Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2014
Fair Value Disclosures [Abstract]	'
Fair Value, Assets Measured on Recurring Basis [Table Text Block]	'
				Fair Value Measurement Using
		30-Jun-14		Quoted prices in		Significant		Significant
				active markets		other observable		unobservable
				(Level 1)		inputs (Level 2)		inputs (Level 3)
	Asset Category
	Money market accounts	$	56,767	$	56,767	$	-	$	-
	Available for sale equity securities		2,315		1,507		808		-
	Total	$	59,082	$	58,274	$	808	$	-
	Liability Category
	Long term contingent consideration	$	58,600	$	-	$	-	$	58,600
				Fair Value Measurement Using
		31-Dec-13		Quoted prices in		Significant		Significant
				active markets		other observable		unobservable
				(Level 1)		inputs (Level 2)		inputs (Level 3)
	Asset Category
	Money market accounts	$	78,633	$	78,633	$	-	$	-
	Available for sale equity securities		2,302		1,470		832		-
	Derivatives		163		-		163		-
	Total	$	81,098	$	80,103	$	995	$	-
	Liability Category
	Long term contingent consideration	$	34,800	$	-	$	-	$	34,800
Fair Value Measurements, Nonrecurring [Table Text Block]	'
		30-Jun-14				31-Dec-13
		Carrying		Fair Value		Carrying		Fair Value
		Value				Value
	First lien credit facility, including current portion	$	747,450	$	747,450	$	751,225	$	752,637

Note_11_Stockholders_Equity_Ta

Note 11 - Stockholders' Equity (Tables)	6 Months Ended
	Jun. 30, 2014
Note 11 - Stockholders' Equity (Tables) [Line Items]	'
Schedule of Income Tax Provision (Benefit) Allocated to Other Comprehensive Income [Table Text Block]	'
		For the three months ended June 30,								For the six months ended June 30,
		2014				2013				2014					2013
		(Successor)				(Predecessor)				(Successor)					(Predecessor)
	Foreign currency translation adjustment	$	-			$	-			$	-				$	-
	Unrealized gain loss on available for sale securities		(20	)			33				(2	)				(17	)
	Pension and postretirement plans		-				-				11					-
	Derivative valuation		73				(45	)			63					227
	Income tax benefit (provision) related to other comprehensive income	$	53			$	(12	)		$	72				$	210
Successor [Member]	'
Note 11 - Stockholders' Equity (Tables) [Line Items]	'
Schedule of Stockholders Equity [Table Text Block]	'
	Successor
		Preferred Stock							Common Stock
		Shares			Amount				Shares				Amount				Additional			Accumulated			Accumulated			Total			Non-			Total equity
																	Paid-in			Deficit			other comprehensive income (loss)			Stockholders'			controlling
																	Capital									Equity			interest
	Balance at December 31, 2013		2,000,000		$	-				103,571,941			$	-			$	1,212,038		$	(194,222	)	$	1,265		$	1,019,081		$	96,021		$	1,115,102
	Impact of Domestication		-			20				-				1,016				(1,036	)		-			-			-			-			-
	Issuance of common shares @ $11.00 per share on January 5, 2014		-			-				3,959				-				44			-			-			44			-			44
	Exercise of warrants for common shares @ $11.50 per share		-			-				16,244,694				163				186,652			-			-			186,815			-			186,815
	Issuance of common shares @$19.00 per share in connection with Private Placement Offering									15,800,000				158				300,042			-			-			300,200			-			300,200
	Issuance costs in connection with Private Placement Offering		-			-				-				-				(13,433	)		-			-			(13,433	)		-			(13,433	)
	Issuance of common shares @$11.00 per share in connection with 401(k) Exchange Agreement		-			-				1,670,386				16				18,358			-			-			18,374			-			18,374
	Recovery of short swing profits, net		-			-				-				-				515			-			-			515			-			515
	Equity compensation expense		-			-				-				-				303			-			-			303			-			303
	Net (loss) income		-			-				-				-				-			(7,794	)		-			(7,794	)		3,334			(4,460	)
	Foreign currency translation adjustments		-			-				-				-				-			-			22,975			22,975			14			22,989
	Pension and postretirement plans, tax benefit of $11		-			-				-				-				-			-			228			228			-			228
	Derivatives valuation, net of tax benefit of $63		-			-				-				-				-			-			(100	)		(100	)		-			(100	)
	Unrealized gain on available for sale equity securities, net of tax provision of $2		-			-				-				-				-			-			4			4			-			4
	Distribution to non-controlling interest		-			-				-				-				-			-			-			-			(380	)		(380	)
	Balance at June 30, 2014		2,000,000		$	20				137,290,980			$	1,353			$	1,703,483		$	(202,016	)	$	24,372		$	1,527,212		$	98,989		$	1,626,201
Successor From Inception [Member]	'
Note 11 - Stockholders' Equity (Tables) [Line Items]	'
Schedule of Stockholders Equity [Table Text Block]	'
	Successor
		Preferred Stock							Common Stock
		Shares			Amount				Shares				Amount				Additional			Accumulated			Total
																	Paid-in			Deficit			Stockholders'
																	Capital						Equity
	Balance at April 23, 2013 (Inception)		-		$	-				-			$	-			$	-		$	-		$	-
	Issuance of preferred shares @ $10.00 per share on April 25, 2013		2			-				-				-				-			-			-
	Issuance of preferred shares @ $10.00 per share with matching warrants on May 22, 2013 along with 2 matching warrants matching with previously issued preferred shares		1,999,998			-				-				-				20,000			-			20,000
	Issuance of common shares @ $10.00 per share with matching warrants on May 22, 2013		-			-				88,529,500				-				885,296			-			885,296
	Equity offering cost		-			-				-				-				(24,078	)		-			(24,078	)
	Equity compensation expense		-			-				-				-				49			-			49
	Net loss		-			-				-				-				-			(80	)		(80	)
	Balance at June 30, 2013		2,000,000		$	-				88,529,500			$	-			$	881,267		$	(80	)	$	881,187
Predecessor [Member]	'
Note 11 - Stockholders' Equity (Tables) [Line Items]	'
Schedule of Stockholders Equity [Table Text Block]	'
	Predecessor
		Series A			Series B				Common				Additional				Accumulated			Accumulated			Treasury			Total			Non-			Total equity
		Preferred			Preferred				Shares				Paid-In				deficit			other comprehensive			Stock			Stockholders'			controlling			(deficit)
		Shares			Shares								Capital							income (loss)						Equity			interest
	Balance at December 31, 2012	$	525,027		$	-			$	50,000			$	2,318			$	(273,086	)	$	(30,270	)	$	(1,264	)	$	272,725		$	(288	)	$	272,437
	Net income		-			-				-				-				9,393			-			-			9,393			180			9,573
	Equity compensation		-			-				-				78				-			-			-			78			-			78
	Accrual of paid in kind dividend on cumulative preferred shares		20,805			267				-				-				(21,072	)		-			-			-			-			-
	Foreign currency translation adjustments		-			-				-				-				-			(22,009	)		-			(22,009	)		(32	)		(22,041	)
	Derivatives valuation, net of tax  benefit of $227		-			-				-				-				-			(423	)		-			(423	)		-			(423	)
	Unrealized loss on available for sale equity securities, net of tax expense of $17		-			-				-				-				-			32			-			32			-			32
	Shares repurchased		(500,000	)		-				-														(8	)		(500,008	)		-			(500,008	)
	Shares exchanged		(44,977	)		44,977				-																	-			-			-
	Shares canceled		(855	)		-				(417	)													1,272			-			-			-
	Dividend paid to non-controlling interest partner		-			-				-				-				-			-			-			-			(304	)		(304	)
	Contribution from non-controlling interest		-			-				-				-				-			-			-			-			17			17
	Balance at June 30, 2013	$	-		$	45,244			$	49,583			$	2,396			$	(284,765	)	$	(52,670	)	$	-		$	(240,212	)	$	(427	)	$	(240,639	)

Note_12_Earnings_Per_Share_Tab

Note 12 - Earnings Per Share (Tables)	6 Months Ended
	Jun. 30, 2014
Earnings Per Share [Abstract]	'
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	'
	(in thousands)	Three months ended			Period from			Six months ended			Period from
		30-Jun-14			Inception			30-Jun-14			Inception
					(April 23, 2013)						(April 23, 2013)
					through June 30, 2013						through June 30, 2013
	Net income attributable to common shareholders	$	(376	)	$	(80	)	$	(7,794	)	$	(80	)
	Basic weighted average common shares outstanding		128,595			88,529			117,937			88,529
	Dilutive weighted average common shares outstanding 1		128,595			88,529			117,937			88,529
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	'
		Three months ended			Six months ended
		30-Jun-14			30-Jun-14
	Number of shares contingently issuable for founder preferred share dividend rights		11,279			11,279
	Number of shares issuable upon conversion of the PDH non-controlling interest		8,775			8,775
	Number of shares issuable upon conversion of founder preferred shares		2,000			2,000
	Number of shares contingently issuable for the contingent consideration		713			713
	Number of warrants		-			2,243
	Number of shares issuable upon conversion of the 401k exchange rights		-			544
	Number of stock options		88			80
	Number of restricted stock shares and units		2			1
			22,857			25,635

Note_13_Contingencies_Environm1

Note 13 - Contingencies, Environmental and Legal Matters (Tables)	6 Months Ended
	Jun. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Legal Matters and Contingencies [Text Block]	'
		30-Jun-14		31-Dec-13
	Accrued expenses and other current liabilities	$	463	$	69
	Other long-term liabilities		4,901		4,696
		$	5,364	$	4,765

Note_16_Restructuring_Activiti1

Note 16 - Restructuring Activities (Tables)	6 Months Ended
	Jun. 30, 2014
Restructuring and Related Activities [Abstract]	'
Restructuring Expense [Table Text Block]	'
		For the three months ended June 30,						For the six months ended June 30,
		2014			2013			2014				2013
		(Successor)			(Predecessor)			(Successor)				(Predecessor)
	Severance and other benefits	$	404		$	46		$	404			$	1,652
	Total restructuring expense	$	404		$	46		$	404			$	1,652
Restructuring and Related Costs [Table Text Block]	'
				For the Successor Period
	Successor	Balance,		Charges to			Cash			Non-cash				Balance,
		December 31,		Expense			Payments			Adjustments				June 30,
		2013												2014
	Graphic Solutions:
	Severance and other benefits	$	699	$	179		$	(291	)	$	-			$	587
	Total Graphics Solutions		699		179			(291	)		-				587
	Performance Materials:
	Severance and other benefits		1,330		225			(741	)		(76	)			738
	Total Performance Materials		1,330		225			(741	)		(76	)			738
	Total restructuring liability	$	2,029	$	404		$	(1,032	)	$	(76	)		$	1,325
				For the Predecessor Period
	Predecessor	Balance,		Charges to			Cash			Non-cash				Balance,
		December 31,		Expense			Payments			Adjustments				June 30,
		2012												2013
	Graphic Solutions:
	Severance and other benefits	$	-	$	1,508		$	(643	)	$	-			$	865
	Total Graphics Solutions		-		1,508			(643	)		-				865
	Performance Materials:
	Severance and other benefits		632		144			(112	)		(9	)			655
	Total Performance Materials		632		144			(112	)		(9	)			655
	Total restructuring liability	$	632	$	1,652		$	(755	)	$	(9	)		$	1,520

Note_17_Segment_Information_Ta

Note 17 - Segment Information (Tables)	6 Months Ended
	Jun. 30, 2014
Segment Reporting [Abstract]	'
Schedule of Segment Reporting Information, by Segment [Table Text Block]	'
		For the three months ended June 30,					For the six months ended June 30,
		2014			2013		2014			2013
		(Successor)			(Predecessor)		(Successor)			(Predecessor)
	Net Sales:
	Performance Materials	$	147,129		$	145,274	$	290,240		$	284,098
	Graphic Solutions		42,003			44,718		82,618			88,026
	Consolidated net sales		189,132			189,992		372,858			372,124
	Operating profit (loss):
	Performance Materials		16,641			27,115		25,480			48,563
	Graphic Solutions		(11,035	)		9,517		(15,882	)		17,845
	Consolidated operating profit	$	5,606		$	36,632	$	9,598		$	66,408

Note_1_Basis_of_Presentation_a1

Note 1 - Basis of Presentation and Significant Accounting Policies (Details) (USD $)	Jan. 23, 2014	Mar. 04, 2014	Oct. 31, 2013
		MacDermid [Member]	MacDermid [Member]
Note 1 - Basis of Presentation and Significant Accounting Policies (Details) [Line Items]	'	'	'
Business Acquisition, Percentage of Ownership	'	3.00%	97.00%
Share Price (in Dollars per share)	$0.01	'	'

Note_2_Acquisitions_of_Busines2

Note 2 - Acquisitions of Businesses (Details) (USD $)

6 Months Ended

6 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

1 Months Ended

2 Months Ended

3 Months Ended

6 Months Ended

0 Months Ended

1 Months Ended

3 Months Ended

0 Months Ended

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Apr. 16, 2014

Jun. 30, 2014

Dec. 31, 2013

Mar. 31, 2014

Oct. 31, 2013

Mar. 04, 2014

Jan. 31, 2014

Oct. 31, 2013

Mar. 04, 2014

Dec. 31, 2013

Jun. 30, 2014

Dec. 31, 2008

Apr. 16, 2014

Jul. 03, 2014

Mar. 31, 2012

Mar. 31, 2014

Jun. 30, 2014

Jun. 30, 2014

Apr. 16, 2014

Selling, General and Administrative Expenses [Member]

Selling, General and Administrative Expenses [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

Chemtura [Member]

Chemtura [Member]

Specialty Chemical Business [Member]

Specialty Chemical Business [Member]

PDH [Member]

PDH [Member]

Cash [Member]

MacDermid [Member]

Chemtura [Member]

Other Noncurrent Liabilities [Member]

Other Noncurrent Liabilities [Member]

MacDermid Savings Plan [Member]

MacDermid Savings Plan [Member]

MacDermid [Member]

MacDermid [Member]

Chemtura [Member]

Note 2 - Acquisitions of Businesses (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Business Acquisition, Percentage of Ownership

'

'

'

'

'

'

'

3.00%

3.00%

'

97.00%

'

'

'

'

'

'

'

'

'

'

'

Business Combination, Consideration Transferred

'

'

'

'

'

'

'

'

'

'

$1,800,000,000

'

'

'

'

$1,000,000,000

'

$8,900,000

'

'

'

$950,000,000

Business Combination, Consideration Transferred, Liabilities Incurred

'

'

'

'

'

'

'

'

'

'

754,200,000

'

'

'

'

'

'

'

'

'

'

'

Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High

'

'

'

'

'

'

'

'

'

'

100,000,000

'

'

100,000

'

'

'

'

'

'

'

'

Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred

'

'

'

'

'

'

'

'

'

8,540,000

'

'

'

'

'

'

'

'

'

'

'

'

Fair Value Inputs, Discount Rate

'

'

'

'

'

'

'

'

'

'

2.00%

'

'

'

'

'

'

'

'

'

'

'

Fair Value Inputs, Future Value of Cash Payments

'

'

'

'

'

'

'

'

'

'

60,000,000

'

'

'

'

'

'

'

'

'

'

'

Business Combination Contingent Consideration Arrangements Expected Future Value of Payments

'

'

'

'

'

'

'

'

'

'

'

'

40,000,000

'

'

'

'

'

'

'

'

'

Business Combination, Contingent Consideration, Liability

58,600,000

34,800,000

'

'

58,600,000

34,800,000

'

'

'

'

35,500,000

'

'

'

35,500,000

'

'

'

'

'

'

'

Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability

'

'

23,800,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles

'

'

'

'

'

'

'

'

'

'

'

'

'

1,500,000

'

'

'

'

'

'

'

'

Business Acquisition, Share Price (in Dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

$11

'

'

'

'

'

'

'

'

Business Acquisition Proportionate Share of Contingent Consideration

'

'

'

'

'

'

'

'

'

'

'

'

'

100,000,000

'

'

'

'

'

'

'

'

Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners

'

'

'

'

'

'

'

'

'

'

'

'

'

6.76%

'

'

'

'

'

6.76%

'

'

Annual Maximum Percentage of Holdings Exchanged

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

25.00%

'

Common Stock, Capital Shares Reserved for Future Issuance (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

8,800,000

'

'

Redeemable 401k Plan Interest

'

20,972,000

'

'

'

'

'

'

'

'

'

'

20,972,000

'

21,000,000

'

'

'

'

'

'

'

Payments to Acquire Businesses, Gross

'

'

'

'

'

'

2,600,000

'

'

'

'

2,600,000

'

'

'

'

'

'

1,114,000

'

'

'

Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in Shares)

'

'

'

'

'

'

1,670,386

'

'

'

'

1,670,386

'

'

'

2,000,000

'

'

'

'

'

'

Number of Major Product Lines

2

'

'

'

'

'

'

'

'

'

'

'

'

'

'

7

'

'

'

'

'

'

Escrow Deposit

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

315,000,000

'

'

'

'

'

Business Combination, Acquisition Related Costs

'

'

'

$9,900,000

'

'

'

'

'

'

'

'

'

'

'

$5,000,000

'

'

'

'

'

'

Business Acquisition, Percentage of Voting Interests Acquired

'

'

'

'

'

'

'

'

3.00%

'

'

3.00%

'

'

'

'

'

95.00%

'

'

'

'

Note_2_Acquisitions_of_Busines3

Note 2 - Acquisitions of Businesses (Details) - Preliminary Purchase Price Allocation for Businesses Acquired (USD $)

Jun. 30, 2014

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2008

Dec. 31, 2008

Dec. 31, 2008

Dec. 31, 2008

Dec. 31, 2008

Dec. 31, 2008

Dec. 31, 2008

Dec. 31, 2013

Oct. 31, 2013

Dec. 31, 2008

In Thousands, unless otherwise specified

Scenario, Previously Reported [Member]

Scenario, Previously Reported [Member]

Scenario, Previously Reported [Member]

Scenario, Previously Reported [Member]

Restatement Adjustment [Member]

Restatement Adjustment [Member]

Restatement Adjustment [Member]

Restatement Adjustment [Member]

Customer Relationships [Member]

Developed Technology Rights [Member]

Trade Names [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

Customer Relationships [Member]

Developed Technology Rights [Member]

Trade Names [Member]

MacDermid [Member]

Customer Relationships [Member]

Developed Technology Rights [Member]

Trade Names [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

Note 2 - Acquisitions of Businesses (Details) - Preliminary Purchase Price Allocation for Businesses Acquired [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Accounts receivable

'

'

'

'

'

$147,400

'

'

'

'

'

'

'

'

'

$147,400

Inventories

'

'

'

'

'

115,300

'

'

'

'

'

'

'

'

'

115,300

Other current assets

'

'

'

'

'

26,200

'

'

'

'

'

'

'

'

'

26,200

Property, plant and equipment

'

'

'

'

'

142,800

'

'

'

-1,900

'

'

'

'

'

140,900

Intangible assets

'

'

458,400

155,000

73,400

'

35,600

9,200

-2,600

'

494,000

164,200

70,800

'

'

'

Goodwill

1,004,354

989,808

'

'

'

993,800

'

'

'

-3,800

'

'

'

'

'

990,000

Other assets

'

'

'

'

'

30,800

'

'

'

-2,500

'

'

'

'

'

28,300

Accounts payable

'

'

'

'

'

-55,900

'

'

'

'

'

'

'

'

'

-55,900

Other current liabilities

'

'

'

'

'

-62,100

'

'

'

100

'

'

'

'

'

-62,000

Long-term debt

'

'

'

'

'

-754,200

'

'

'

'

'

'

'

'

'

-754,200

Non-current deferred tax liability

'

'

'

'

'

-140,700

'

'

'

-30,500

'

'

'

'

'

-171,200

Contingent consideration

-58,600

-34,800

'

'

'

-35,500

'

'

'

'

'

'

'

'

-35,500

-35,500

Redeemable 401(k) plan interest

'

-20,972

'

'

'

-21,000

'

'

'

'

'

'

'

-20,972

'

-21,000

Other liabilities

'

'

'

'

'

-66,500

'

'

'

'

'

'

'

'

'

-66,500

Total purchase price

'

'

'

'

'

$1,007,200

'

'

'

$3,600

'

'

'

'

'

$1,010,800

Note_3_Inventories_Details

Note 3 - Inventories (Details) (Fair Value Adjustment to Inventory [Member], MacDermid [Member], USD $)	3 Months Ended	6 Months Ended	15 Months Ended
	Dec. 31, 2013	Mar. 31, 2014	Mar. 31, 2014
Fair Value Adjustment to Inventory [Member] | MacDermid [Member]	'	'	'
Note 3 - Inventories (Details) [Line Items]	'	'	'
Assets, Fair Value Adjustment	$23,992	$35,868,000	$11,956

Note_3_Inventories_Details_Com

Note 3 - Inventories (Details) - Components of Inventory (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Components of Inventory [Abstract]	'	'
Finished goods	$49,880	$58,360
Raw materials and supplies	28,761	29,870
Equipment	1,870	1,388
Total inventory, net	$80,511	$89,618

Note_4_Property_Plant_and_Equi2

Note 4 - Property, Plant and Equipment (Details) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Property, Plant and Equipment [Abstract]	'	'	'	'
Depreciation	$5,392,000	$3,162,000	$8,965	$6,314

Note_4_Property_Plant_and_Equi3

Note 4 - Property, Plant and Equipment (Details) - Components of Property, Plant and Equipment (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Property, Plant and Equipment [Line Items]	'	'
Property, Plant and Equipment	$137,574	$132,335
Less: accumulated depreciation	-14,202	-3,900
Property, Plant and Equipment - Net Depreciation	133,641	136,166
Construction in process	10,269	7,731
Land and Land Improvements [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, Plant and Equipment	27,860	29,946
Building and Building Improvements [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, Plant and Equipment	36,290	38,914
Machinery and Equipment [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, Plant and Equipment	73,424	63,475
Excluding Construction in Process [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, Plant and Equipment - Net Depreciation	$123,372	$128,435

Note_5_Goodwill_and_Intangible2

Note 5 - Goodwill and Intangible Assets (Details) (USD $)

6 Months Ended

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

In Thousands, unless otherwise specified

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Successor [Member]

Successor [Member]

Predecessor [Member]

Predecessor [Member]

Customer Relationships [Member]

Customer Relationships [Member]

Customer Relationships [Member]

Developed Technology Rights [Member]

Developed Technology Rights [Member]

Developed Technology Rights [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

Note 5 - Goodwill and Intangible Assets (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

Indefinite-Lived Trade Names (in Dollars)

$71,033

$70,913

'

'

'

'

'

'

'

'

'

'

Finite-Lived Intangible Asset, Useful Life

'

'

'

'

'

'

'

'8 years

'20 years

'

'7 years

'10 years

Acquired Finite-lived Intangible Assets, Weighted Average Useful Life

'15 years

'

'

'

'

'

'16 years

'

'

'10 years

'

'

Amortization of Intangible Assets (in Dollars)

'

'

$16,004

$29,321

$6,692

$13,427

'

'

'

'

'

'

Note_5_Goodwill_and_Intangible3

Note 5 - Goodwill and Intangible Assets (Details) - Changes in the Carrying Amount of Goodwill by Segment (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Goodwill [Line Items]	'	'
Goodwill Balance	$1,004,354	$989,808
Foreign currency translation and other	14,546	'
Goodwill Balance	1,004,354	989,808
Performance Materials [Member]	'	'
Goodwill [Line Items]	'	'
Goodwill Balance	774,460	760,371
Foreign currency translation and other	14,089	'
Goodwill Balance	774,460	760,371
Graphic Solutions [Member]	'	'
Goodwill [Line Items]	'	'
Goodwill Balance	229,894	229,437
Foreign currency translation and other	457	'
Goodwill Balance	$229,894	$229,437

Note_5_Goodwill_and_Intangible4

Note 5 - Goodwill and Intangible Assets (Details) - Intangible Assets Subject to Amortization (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Finite-Lived Intangible Assets [Line Items]	'	'
Gross Carrying Amount	$658,200	$658,200
Accumulated Amortization and Foreign Exchange	-29,790	-8,811
Net Book Value	628,410	649,389
Customer Lists [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Gross Carrying Amount	494,000	494,000
Accumulated Amortization and Foreign Exchange	-19,600	-6,420
Net Book Value	474,400	487,580
Developed Technology Rights [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Gross Carrying Amount	164,200	164,200
Accumulated Amortization and Foreign Exchange	-10,190	-2,391
Net Book Value	$154,010	$161,809

Note_6_Equity_Compensation_Pla1

Note 6 - Equity Compensation Plans (Details) (USD $)

Jan. 31, 2013

Jan. 31, 2013

Jan. 31, 2013

Jan. 31, 2013

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Mar. 31, 2014

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

In Thousands, except Share data, unless otherwise specified

Class C Junior Shares [Member]

Class C Junior Shares [Member]

Class B Junior Shares [Member]

Class B Junior Shares [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock [Member]

The 2013 Plan [Member]

Employee Stock Purchase Plan [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Director [Member]

Employee [Member]

The 2013 Plan [Member]

MacDermid [Member]

Maximum [Member]

MacDermid [Member]

Per Tranch [Member]

MacDermid [Member]

Per Tranch [Member]

MacDermid [Member]

Amended and Restated Incentive Compensation Plan [Member]

Amended and Restated Incentive Compensation Plan [Member]

The 2013 Plan [Member]

MacDermid [Member]

MacDermid [Member]

Note 6 - Equity Compensation Plans (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized

'

'

'

'

'

'

'

'

'

'

15,088,000

'

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

'

5,000,000

1,666,666

'

9,242

72,500

329,823

'

'

'

'

'

Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options (in Dollars)

'

'

'

'

'

'

'

'

$7,100

'

'

'

Allocated Share-based Compensation Expense (in Dollars)

'

'

'

'

$262

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share)

'

'

'

'

'

'

'

'

'

$28.36

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage

'

'

'

'

'

'

'

69.00%

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period

'

'

'

'

'

'

'

'

'

'

'

0

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number

1,630,000

'

'

4,890,000

'

'

'

'

'

'

'

'

Note_7_Pension_PostRetirement_2

Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details) - Components of Net Periodic Pension and Postretirement Benefit Costs (USD $)

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

In Thousands, unless otherwise specified

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2013

Jun. 30, 2013

Jun. 30, 2013

Jun. 30, 2013

Jun. 30, 2013

Jun. 30, 2013

Jun. 30, 2013

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Predecessor [Member]

Predecessor [Member]

Predecessor [Member]

Predecessor [Member]

Predecessor [Member]

Predecessor [Member]

Predecessor [Member]

Predecessor [Member]

Pension and SERP Benefits [Member]

Pension and SERP Benefits [Member]

Pension and SERP Benefits [Member]

Pension and SERP Benefits [Member]

Other Postretirement Benefit Plan [Member]

Other Postretirement Benefit Plan [Member]

Other Postretirement Benefit Plan [Member]

Other Postretirement Benefit Plan [Member]

Pension and SERP Benefits [Member]

Pension and SERP Benefits [Member]

Pension and SERP Benefits [Member]

Pension and SERP Benefits [Member]

Other Postretirement Benefit Plan [Member]

Other Postretirement Benefit Plan [Member]

Other Postretirement Benefit Plan [Member]

Other Postretirement Benefit Plan [Member]

Domestic [Member]

Domestic [Member]

Foreign [Member]

Foreign [Member]

Domestic [Member]

Domestic [Member]

Foreign [Member]

Foreign [Member]

Domestic [Member]

Domestic [Member]

Foreign [Member]

Foreign [Member]

Domestic [Member]

Domestic [Member]

Foreign [Member]

Foreign [Member]

Net periodic cost (benefit):

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Service cost

'

'

$211

$419

$14

$28

$7

$14

$1,078

$2,156

$174

$348

$18

$36

$11

$22

Interest cost on the projected benefit obligation

1,728

3,456

768

1,523

83

166

8

16

1,565

3,130

768

1,536

73

146

10

20

Expected return on plan assets

-2,433

-4,866

-913

-1,811

'

'

'

'

-2,005

-4,010

-1,283

-2,566

'

'

'

'

Amortization of prior service cost

'

'

'

'

'

'

'

'

23

46

'

'

-35

-70

7

14

Amortization of net loss

'

'

'

'

'

'

'

'

505

1,010

135

270

'

'

'

'

Net periodic (benefit) cost

($705)

($1,410)

$66

$131

$97

$194

$15

$30

$1,166

$2,332

($206)

($412)

$56

$112

$28

$56

Note_8_Debt_Details

Note 8 - Debt (Details) (USD $)

0 Months Ended

3 Months Ended

6 Months Ended

12 Months Ended

0 Months Ended

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

0 Months Ended

6 Months Ended

12 Months Ended

0 Months Ended

3 Months Ended

0 Months Ended

6 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

1 Months Ended

1 Months Ended

3 Months Ended

6 Months Ended

Jun. 07, 2013

Jun. 30, 2013

Jun. 30, 2014

Dec. 31, 2013

Oct. 31, 2013

Jun. 07, 2013

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2013

Jun. 30, 2013

Jun. 30, 2013

Jun. 30, 2013

Jun. 30, 2013

Jun. 30, 2013

Oct. 31, 2013

Apr. 12, 2007

Jun. 30, 2013

Jun. 30, 2013

Apr. 12, 2007

Oct. 31, 2013

Apr. 12, 2007

Apr. 16, 2014

Jun. 07, 2013

Jun. 07, 2013

Jun. 07, 2013

Jun. 30, 2014

Dec. 31, 2013

Jun. 07, 2013

Jun. 30, 2014

Dec. 31, 2013

Oct. 31, 2013

Jun. 07, 2013

Jun. 07, 2013

Jun. 30, 2013

Jun. 07, 2013

Jul. 08, 2013

Jun. 07, 2013

Jun. 07, 2013

Jun. 07, 2013

Jul. 08, 2013

Apr. 16, 2014

Oct. 31, 2013

Jun. 30, 2014

Oct. 31, 2009

Sep. 30, 2007

Feb. 28, 2007

Jun. 30, 2013

Jun. 30, 2013

Jun. 30, 2014

Predecessor Recapitalization and Refinancing [Member]

Redemption of Series A Preferred Stock and Accumulated Dividends [Member]

Redemption of Series A Preferred Stock and Accumulated Dividends [Member]

Quarterly Payment [Member]

Quarterly Payment [Member]

Predecessor [Member]

Predecessor [Member]

Predecessor [Member]

Tranche B Term Loan [Member]

Tranche B Term Loan [Member]

Tranche B Term Loan [Member]

Tranche B Term Loan [Member]

Tranche C Term Loan [Member]

Tranche C Term Loan [Member]

Tranche C Term Loan [Member]

First Lien Facilities [Member]

First Lien Facilities [Member]

First Lien Facilities [Member]

First Lien Term Loan [Member]

First Lien Term Loan [Member]

First Lien Term Loan [Member]

First Lien Term Loan [Member]

First Lien Term Loan [Member]

First Lien Term Loan [Member]

First Lien Term Loan [Member]

First Lien Term Loan [Member]

First Lien Term Loan [Member]

Second Lien Term Loan [Member]

Second Lien Term Loan [Member]

Second Lien Term Loan [Member]

Predecessor Senior Subordinated Notes [Member]

Predecessor Senior Subordinated Notes [Member]

Predecessor Senior Subordinated Notes [Member]

Predecessor Senior Subordinated Notes [Member]

Predecessor Senior Subordinated Notes [Member]

Predecessor Senior Subordinated Notes [Member]

Second Lien Facility [Member]

Second Lien Facility [Member]

Overdraft Facility [Member]

Japanese Senior Secured Bank Debt [Member]

Japanese Senior Secured Bank Debt [Member]

Japanese Senior Secured Bank Debt [Member]

Series A Preferred Stock [Member]

Series B Preferred Stock [Member]

Revolving Credit Facility [Member]

Predecessor Senior Subordinated Notes [Member]

Tranche B Term Loan [Member]

Tranche C Term Loan [Member]

Tranche C Term Loan [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Chemtura [Member]

Multi-currency [Member]

Revolving Credit Facility [Member]

London Interbank Offered Rate (LIBOR) [Member]

London Interbank Offered Rate (LIBOR) [Member]

London Interbank Offered Rate (LIBOR) [Member]

London Interbank Offered Rate (LIBOR) [Member]

Senior Subordinated Notes [Member]

Senior Subordinated Notes [Member]

Senior Subordinated Notes [Member]

Senior Subordinated Notes [Member]

Senior Subordinated Notes [Member]

Senior Subordinated Notes [Member]

Chemtura [Member]

Maximum [Member]

Secured Debt [Member]

Secured Debt [Member]

Secured Debt [Member]

Senior Subordinated Notes [Member]

Revolving Credit Facility [Member]

Subordinated Debt [Member]

Subordinated Debt [Member]

Subordinated Debt [Member]

Redemption Premium [Member]

Redemption Premium [Member]

Redemption Premium [Member]

Note 8 - Debt (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Maximum Borrowing Capacity

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$360,000,000

'

'

'

$50,000,000

$50,000

$600,000,000

$25,000,000

$25,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$120,000,000

'

'

'

'

'

'

'

'

Debt Instrument, Face Amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

360,000,000

'

'

'

250,000

'

'

'

'

'

'

'

'

755,000,000

'

'

'

'

360,000,000

'

'

'

'

'

'

'

'

'

'

5,569,000

2,519,000

15,000,000

'

'

'

Long-term Debt

'

'

747,450,000

751,225,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

805,000,000

747,450,000

751,225,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Interest Rate, Stated Percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4.00%

4.00%

4.00%

'

'

'

'

7.75%

'

'

'

'

'

'

'

'

'

6.25%

'

'

'

'

'

'

Debt Instrument, Basis Spread on Variable Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3.00%

3.00%

3.00%

'

'

'

'

6.75%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Periodic Payment, Principal

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,878,000

1,888,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Maturity Date

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

7-Jun-18

'

'

'

7-Jun-20

'

'

'

'

7-Dec-20

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Unamortized Discount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,887,000

'

'

1,775,000

'

3,600,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Guaranteed Credit Facilities, Stock of the Company's First Tier Foreign Subsidiaries, Percentage

65.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Issuance of Senior Long-term Debt

'

'

'

'

'

105,864,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

105,864,000

'

'

'

'

'

'

'

'

'

'

Early Repayment of Senior Debt

'

'

'

'

'

100,481,000

'

'

'

'

'

'

'

1,762,000

'

'

'

'

138,737,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

100,481,000

'

249,519,000

'

'

'

'

'

'

'

'

'

'

Repayments of Senior Debt

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3,182,000

3,182,000

'

9,357,000

'

'

'

'

'

'

'

'

'

'

'

Interest Expense, Debt

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,201,000

2,201,000

'

'

'

'

'

'

'

'

'

Repayments Of Debt And Other Uses

'

'

1,232,080,000

'

'

'

500,000,000

500,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Dividend Rate, Percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

9.00%

9.50%

'

Stock Issued During Period, Value, New Issues

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

44,977,000

'

Gains (Losses) on Extinguishment of Debt

'

18,788,000

'

'

'

'

'

'

'

'

'

-18,788,000

-18,788,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Bond Retirement Premiums Included in Loss in Recapitalization and Refinancing

'

12,539,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Write off of Deferred Debt Issuance Cost

'

6,249,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Deferred Finance Costs, Gross

'

13,003,000

'

'

13,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Amortization of Deferred Financing Costs Term

'

'7 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Repayments of Long-term Debt

'

'

'

'

'

'

'

'

1,628,000

206,479,000

6,810,000

'

'

'

10,277,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

373,000,000

'

'

'

'

'

'

'

Debt Instrument, Periodic Payment, Interest

'

'

'

'

'

'

'

'

'

'

'

'

'

7,577,000

'

'

'

3,775,000

15,089,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,628,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Letters of Credit Outstanding, Amount

'

'

989,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Minimum Amount Outstanding Subject to Covenant Terms

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

12,500,000

Short-term Debt

'

'

0

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Overdraft Facility, Maximum Capacity

'

'

23,028,000

22,075,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Expenses and Losses, Reporting Currency Denominated, Value

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

7,084,000

3,261,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Revenues and Gains, Reporting Currency Denominated, Value

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$4,074,000

$4,398,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Note_8_Debt_Details_Current_an

Note 8 - Debt (Details) - Current and Long-Term Debt (USD $)	Jun. 30, 2014	Dec. 31, 2013	Jun. 07, 2013
In Thousands, unless otherwise specified
Note 8 - Debt (Details) - Current and Long-Term Debt [Line Items]	'	'	'
First lien secured credit facility, due 2020, interest at the greater of 4.00% or LIBOR plus 3.00%, weighted average interest rate of 4.00% at June 30, 2014	$747,450	$751,225	'
Other	1,000	1,024	'
Total debt	748,450	752,249	'
Less: current portion debt	-7,953	-7,958	'
Total long-term debt	740,497	744,291	'
First Lien Term Loan [Member]	'	'	'
Note 8 - Debt (Details) - Current and Long-Term Debt [Line Items]	'	'	'
First lien secured credit facility, due 2020, interest at the greater of 4.00% or LIBOR plus 3.00%, weighted average interest rate of 4.00% at June 30, 2014	$747,450	$751,225	$805,000

Note_8_Debt_Details_Current_an1

Note 8 - Debt (Details) - Current and Long-Term Debt (Parentheticals) (First Lien Term Loan [Member])	0 Months Ended	6 Months Ended	12 Months Ended
	Jun. 07, 2013	Jun. 30, 2014	Dec. 31, 2013
Note 8 - Debt (Details) - Current and Long-Term Debt (Parentheticals) [Line Items]	'	'	'
Interest rate	4.00%	'	'
London Interbank Offered Rate (LIBOR) [Member]	'	'	'
Note 8 - Debt (Details) - Current and Long-Term Debt (Parentheticals) [Line Items]	'	'	'
Interest rate	'	4.00%	4.00%
Interest LIBOR plus	3.00%	3.00%	3.00%
Weighted Average [Member]	'	'	'
Note 8 - Debt (Details) - Current and Long-Term Debt (Parentheticals) [Line Items]	'	'	'
Weighted Average Interest Rate	'	4.00%	'

Note_8_Debt_Details_The_Recapi

Note 8 - Debt (Details) - The Recapitalization and Refinancing Transactions Sources and Uses of Cash (USD $)	3 Months Ended	6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2013	Jun. 30, 2014
Note 8 - Debt (Details) - The Recapitalization and Refinancing Transactions Sources and Uses of Cash [Line Items]	'	'
Sources of cash	'	$1,232,080
Uses of cash	'	1,232,080
First Lien Term Loan [Member]	'	'
Note 8 - Debt (Details) - The Recapitalization and Refinancing Transactions Sources and Uses of Cash [Line Items]	'	'
Sources of cash	'	755,000
Second Lien Term Loan [Member]	'	'
Note 8 - Debt (Details) - The Recapitalization and Refinancing Transactions Sources and Uses of Cash [Line Items]	'	'
Sources of cash	'	360,000
Sources, Cash [Member]	'	'
Note 8 - Debt (Details) - The Recapitalization and Refinancing Transactions Sources and Uses of Cash [Line Items]	'	'
Sources of cash	'	117,080
Retaire Tranche B and Tranche C Term Loans and Accrued Interest [Member]	'	'
Note 8 - Debt (Details) - The Recapitalization and Refinancing Transactions Sources and Uses of Cash [Line Items]	'	'
Uses of cash	'	345,426
Retire Senior Subordinated Notes, Accrued Interest and Call Premiums [Member]	'	'
Note 8 - Debt (Details) - The Recapitalization and Refinancing Transactions Sources and Uses of Cash [Line Items]	'	'
Uses of cash	'	368,164
Redemption of Series A Preferred Stock and Accumulated Dividends [Member]	'	'
Note 8 - Debt (Details) - The Recapitalization and Refinancing Transactions Sources and Uses of Cash [Line Items]	'	'
Uses of cash	500,000	500,000
Fees and Expenses [Member]	'	'
Note 8 - Debt (Details) - The Recapitalization and Refinancing Transactions Sources and Uses of Cash [Line Items]	'	'
Uses of cash	'	13,003
Discount on First and Second Term loans [Member]	'	'
Note 8 - Debt (Details) - The Recapitalization and Refinancing Transactions Sources and Uses of Cash [Line Items]	'	'
Uses of cash	'	$5,487

Note_9_Derivative_Instruments_1

Note 9 - Derivative Instruments (Details) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Note 9 - Derivative Instruments (Details) [Line Items]	'	'	'	'
Revenues Denominated in U.S. Dollars, Percentage	25.00%	'	25.00%	'
Foreign Exchange Contract [Member]	'	'	'	'
Note 9 - Derivative Instruments (Details) [Line Items]	'	'	'	'
Derivative Asset, Notional Amount	$0	'	$0	'
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax	178	130	163	650
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax	$315	$111	$474	$334

Note_9_Derivative_Instruments_2

Note 9 - Derivative Instruments (Details) - Fair Value of Derivative Instruments Reported in the Balance Sheets (USD $)	Dec. 31, 2013
In Thousands, unless otherwise specified
Derivatives, Fair Value [Line Items]	'
Foreign exchange contracts	$163
Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Other Current Assets [Member]	'
Derivatives, Fair Value [Line Items]	'
Foreign exchange contracts	$163

Note_10_Fair_Value_Measurement2

Note 10 - Fair Value Measurements (Details) (USD $)	6 Months Ended		3 Months Ended
	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2013	Jun. 30, 2014	Oct. 31, 2013
			Selling, General and Administrative Expenses [Member]	Graphic Solutions [Member]	MacDermid [Member]	MacDermid [Member]
Note 10 - Fair Value Measurements (Details) [Line Items]	'	'	'	'	'	'
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High	'	'	'	'	$100,000	$100,000,000
Indefinite-Lived Intangible Assets (Excluding Goodwill)	'	'	'	4,300	'	'
Indefinite-lived Intangible Assets (Excluding Goodwill), Fair Value Disclosure	'	'	'	3,900	'	'
Impairment of Intangible Assets (Excluding Goodwill)	$400	'	$400	'	'	'
Investment Net Asset Value (in Dollars per share)	'	$1	'	'	'	'

Note_10_Fair_Value_Measurement3

Note 10 - Fair Value Measurements (Details) - Financial Instruments, Assets and Liabilities Measured at Fair Value (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Asset Category	'	'
Money market accounts	$56,767	$78,633
Available for sale equity securities	2,315	2,302
Derivatives	'	163
Total	59,082	81,098
Liability Category	'	'
Long term contingent consideration	58,600	34,800
Fair Value, Inputs, Level 1 [Member]	'	'
Asset Category	'	'
Money market accounts	56,767	78,633
Available for sale equity securities	1,507	1,470
Total	58,274	80,103
Fair Value, Inputs, Level 2 [Member]	'	'
Asset Category	'	'
Available for sale equity securities	808	832
Derivatives	'	163
Total	808	995
Fair Value, Inputs, Level 3 [Member]	'	'
Liability Category	'	'
Long term contingent consideration	$58,600	$34,800

Note_10_Fair_Value_Measurement4

Note 10 - Fair Value Measurements (Details) - Carrying Value and Estimated Fair Value of the Companybs First Lien Loan (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Carrying Value and Estimated Fair Value of the Companybs First Lien Loan [Abstract]	'	'
First lien credit facility, including current portion	$747,450	$751,225
First lien credit facility, including current portion	$747,450	$752,637

Note_11_Stockholders_Equity_De

Note 11 - Stockholders' Equity (Details) (USD $)

0 Months Ended

1 Months Ended

3 Months Ended

4 Months Ended

0 Months Ended

1 Months Ended

1 Months Ended

4 Months Ended

1 Months Ended

2 Months Ended

3 Months Ended

6 Months Ended

1 Months Ended

Apr. 03, 2014

Jun. 30, 2014

22-May-13

Jun. 30, 2014

Apr. 30, 2014

Jun. 12, 2014

Jun. 11, 2014

Mar. 04, 2014

Jan. 23, 2014

Dec. 31, 2013

Jun. 13, 2014

Jun. 19, 2014

20-May-14

22-May-13

22-May-13

Apr. 30, 2014

Mar. 04, 2014

22-May-13

Jun. 30, 2014

22-May-13

Mar. 04, 2014

Jun. 30, 2014

Jun. 30, 2014

22-May-13

22-May-13

22-May-13

Jun. 30, 2014

22-May-13

Apr. 25, 2013

Private Placement [Member]

Private Placement [Member]

Private Placement [Member]

Warrant [Member]

Warrant [Member]

Warrant [Member]

Warrant [Member]

Warrant Exchange Offer [Member]

IPO [Member]

Criteria [Member]

MacDermid [Member]

MacDermid [Member]

MacDermid [Member]

Non-founder Directors [Member]

Founders [Member]

Two Independent Directors [Member]

Founders [Member]

Founders [Member]

Founders [Member]

Warrants and Rights Subject to Mandatory Redemption [Member]

Note 11 - Stockholders' Equity (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Shares Authorized

'

400,000,000

'

400,000,000

'

400,000,000

200,000,000

'

'

200,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share Price (in Dollars per share)

'

'

'

'

'

'

'

'

$0.01

'

'

'

'

'

'

'

'

'

$10

$18

'

'

'

$10

$10.50

$10.50

'

'

$20

Preferred Stock, Shares Issued

'

2,000,000

2,000,000

2,000,000

'

'

'

'

'

2,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,999,998

'

Preferred Stock, Par or Stated Value Per Share (in Dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.01

'

Preferred Stock, Value, Issued (in Dollars)

'

$20,000

'

$20,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$20,000

'

Preferred Stock, Ordinary Share Market Price Appreciation Dividend Percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

20.00%

'

'

Common Stock, Shares, Issued

'

137,290,980

'

137,290,980

'

'

'

'

'

103,571,941

'

'

'

'

'

'

'

'

90,500,000

'

'

'

'

'

'

'

'

'

'

Convertible Preferred Stock, Shares Issued upon Conversion

'

1

'

1

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Dividends, Shares

'

11,300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, New Issues

'

'

88,500,000

1,251,744

16,244,694

'

'

'

'

'

'

'

15,800,000

'

'

'

'

13,462,280

'

'

'

'

'

29,500

380,952

190,476

'

'

'

Proceeds from Issuance Initial Public Offering (in Dollars)

'

'

885,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Outstanding

'

'

'

'

'

'

'

'

'

'

'

'

'

90,529,500

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$11.50

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Exercisable Time Period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'3 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Warrant Redemption Price (in Dollars)

0.01

'

'

'

'

'

'

'

'

'

'

'

'

'

0.01

'

0.01

'

'

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Threshold Consecutive Trading Days

'

'

'10 days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Sale of Stock, Price Per Share (in Dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$10.50

'

'

'

'

'

'

'

'

'

'

'

Warrants Exchanged Per Common Share

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3

'

'

'

'

'

'

'

'

'

'

'

Warrants Exchanged for Common Stock

'

'

'

3,755,232

'

'

'

'

'

'

'

'

'

'

'

48,734,082

'

40,386,840

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Issuance of Common Stock (in Dollars)

'

'

'

'

'

'

'

'

'

'

'

'

300,200,000

'

'

'

'

141,354

'

'

'

'

'

'

'

'

'

'

'

Business Acquisition, Percentage of Voting Interests Acquired

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3.00%

'

'

'

'

'

'

'

'

Payments to Acquire Businesses, Gross (in Dollars)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,600,000

'

'

'

'

'

'

'

'

Business Acquisition, Equity Interest Issued or Issuable, Number of Shares

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,670,386

'

'

'

'

'

'

'

'

Common Stock, Shares Issued Upon Conversion

'

'

'

'

'

'

'

1

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Par or Stated Value Per Share (in Dollars per share)

'

$0.01

'

$0.01

'

'

'

$0.01

'

$0.01

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Series A Preferred Stock Shares Issued Upon Conversion

'

'

'

'

'

'

'

1

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Warrant Exercises (in Dollars)

'

'

'

14,395

186,814

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Warrants Redeemed

8,580

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Payments of Stock Issuance Costs (in Dollars)

'

'

'

'

'

'

'

'

'

'

'

'

13,433,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of Common Stock on Registration Statement

'

'

'

'

'

'

'

'

'

'

14,825,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of Shares Eligible for Resale

'

'

'

'

'

'

'

'

'

'

'

14,825,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Business Acquisition, Equity Interest Issued or Issuable, Value Assigned (in Dollars)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

97,500,000

97,500,000

'

'

'

'

'

'

Income (Loss) Attributable to Noncontrolling Interest (in Dollars)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1,314,000

$3,068,000

'

'

'

'

'

'

Note_11_Stockholders_Equity_De1

Note 11 - Stockholders' Equity (Details) - Successor Reconciliation of Consolidated Changes in Equity (USD $)

1 Months Ended

3 Months Ended

4 Months Ended

6 Months Ended

1 Months Ended

2 Months Ended

6 Months Ended

6 Months Ended

2 Months Ended

6 Months Ended

6 Months Ended

2 Months Ended

6 Months Ended

2 Months Ended

6 Months Ended

6 Months Ended

6 Months Ended

6 Months Ended

6 Months Ended

2 Months Ended

3 Months Ended

6 Months Ended

In Thousands, except Share data, unless otherwise specified

22-May-13

Jun. 30, 2014

Apr. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

20-May-14

Jun. 30, 2013

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2013

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2014

Dec. 31, 2013

Exchange of Warrants [Member]

Exchange of Warrants [Member]

Exchange of Warrants [Member]

Exchange of Warrants [Member]

Private Placement [Member]

Private Placement [Member]

Private Placement [Member]

Private Placement [Member]

Private Placement [Member]

Preferred Stock [Member]

Preferred Stock [Member]

Preferred Stock [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Additional Paid-in Capital [Member]

Additional Paid-in Capital [Member]

Additional Paid-in Capital [Member]

Additional Paid-in Capital [Member]

Retained Earnings [Member]

Retained Earnings [Member]

Retained Earnings [Member]

Accumulated Other Comprehensive Income (Loss) [Member]

Accumulated Other Comprehensive Income (Loss) [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Noncontrolling Interest [Member]

Noncontrolling Interest [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Common Stock [Member]

Additional Paid-in Capital [Member]

Parent [Member]

Successor [Member]

Common Stock [Member]

Additional Paid-in Capital [Member]

Parent [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

United States Postretirement Benefit Plan of US Entity [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

United States Postretirement Benefit Plan of US Entity [Member]

United States Postretirement Benefit Plan of US Entity [Member]

United States Postretirement Benefit Plan of US Entity [Member]

Note 11 - Stockholders' Equity (Details) - Successor Reconciliation of Consolidated Changes in Equity [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Balance, shares (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

2,000,000

2,000,000

2,000,000

'

88,529,500

137,290,980

103,571,941

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Balance

'

$1,626,201

'

$1,115,102

'

'

'

'

'

'

'

'

'

'

$20

'

'

'

$1,353

'

'

$881,267

$1,703,483

$1,212,038

($80)

($202,016)

($194,222)

$24,372

$1,265

'

$1,527,212

$1,019,081

$98,989

$96,021

'

$881,187

$1,626,201

$1,626,201

$1,115,102

Impact of Domestication

'

'

'

'

'

'

'

'

'

'

'

'

'

'

20

'

'

'

1,016

'

'

'

-1,036

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Balance, shares (in Shares)

88,500,000

1,251,744

16,244,694

'

'

'

'

'

15,800,000

'

'

'

15,800,000

2

'

'

'

88,529,500

3,959

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Balance

'

'

'

'

'

'

'

'

158

300,042

300,200

300,200

'

'

'

'

'

885,296

'

'

'

885,296

44

'

'

'

'

'

'

'

44

'

'

'

'

'

'

44

'

Issuance costs in connection with Private Placement Offering

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

24,078

-13,433

'

'

'

'

'

'

'

-13,433

'

'

'

'

24,078

'

-13,433

'

Issuance of common shares @$11.00 per share in connection with 401(k) Exchange Agreement (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,670,386

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Issuance of common shares @$11.00 per share in connection with 401(k) Exchange Agreement

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

16

'

'

'

18,358

'

'

'

'

'

'

'

'

18,374

'

'

'

'

18,374

'

'

'

'

Recovery of short swing profits, net

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

515

'

'

'

'

'

'

'

515

'

'

'

'

'

'

515

'

Equity compensation expense

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

303

'

'

'

'

'

'

'

303

'

'

'

'

'

'

303

'

Net (loss) income

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-80

-7,794

'

'

'

'

-7,794

'

3,334

'

'

-80

1,488

-4,460

'

Foreign currency translation adjustments

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

22,975

'

'

22,975

'

14

'

'

'

'

22,989

'

Pension and postretirement plans, tax benefit of $11

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

228

'

'

228

'

'

'

'

'

'

228

'

Derivatives valuation, net of tax benefit of $63

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-100

'

'

-100

'

'

'

'

'

'

-100

'

Unrealized gain on available for sale equity securities, net of tax provision of $2

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4

'

'

4

'

'

'

'

'

'

4

'

Distribution to non-controlling interest

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-380

'

'

'

'

-380

'

Exercise of warrants for common shares @ $11.50 per share (in Shares)

'

'

'

'

16,244,694

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Exercise of warrants for common shares @ $11.50 per share

'

'

'

'

$163

$186,652

$186,815

$186,815

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Note_11_Stockholders_Equity_De2

Note 11 - Stockholders' Equity (Details) - Successor Reconciliation of Consolidated Changes in Equity (Parentheticals) (Successor [Member], USD $)	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Note 11 - Stockholders' Equity (Details) - Successor Reconciliation of Consolidated Changes in Equity (Parentheticals) [Line Items]	'	'
Issuance common shares per share	$11	$10
Exercise of warrants per share	$11	$10
Pension and postretirement plans, tax benefit (in Dollars)	$11,000	'
Derivatives valuation, net of tax benefit (in Dollars)	63,000	'
Unrealized gain on available for sale equity securities, net of tax provision (in Dollars)	$2,000	'
Exchange of Warrants [Member]	'	'
Note 11 - Stockholders' Equity (Details) - Successor Reconciliation of Consolidated Changes in Equity (Parentheticals) [Line Items]	'	'
Issuance common shares per share	$11.50	'
Exercise of warrants per share	$11.50	'
Private Placement [Member]	'	'
Note 11 - Stockholders' Equity (Details) - Successor Reconciliation of Consolidated Changes in Equity (Parentheticals) [Line Items]	'	'
Issuance common shares per share	$19	'
Exercise of warrants per share	$19	'
United States Postretirement Benefit Plan of US Entity [Member]	'	'
Note 11 - Stockholders' Equity (Details) - Successor Reconciliation of Consolidated Changes in Equity (Parentheticals) [Line Items]	'	'
Issuance common shares per share	$11	'
Exercise of warrants per share	$11	'

Note_11_Stockholders_Equity_De3

Note 11 - Stockholders' Equity (Details) - Successor Equity Reconciliation from Inception (USD $)

1 Months Ended

3 Months Ended

4 Months Ended

2 Months Ended

2 Months Ended

6 Months Ended

2 Months Ended

6 Months Ended

2 Months Ended

6 Months Ended

2 Months Ended

3 Months Ended

6 Months Ended

In Thousands, except Share data, unless otherwise specified

22-May-13

Jun. 30, 2014

Apr. 30, 2014

Dec. 31, 2013

Jun. 30, 2013

Jun. 30, 2013

Jun. 30, 2013

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2013

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2013

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2013

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2014

Dec. 31, 2013

Matching Warrants [Member]

Matching Warrants [Member]

Preferred Stock [Member]

Preferred Stock [Member]

Preferred Stock [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Additional Paid-in Capital [Member]

Additional Paid-in Capital [Member]

Additional Paid-in Capital [Member]

Retained Earnings [Member]

Retained Earnings [Member]

Retained Earnings [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Preferred Stock [Member]

Additional Paid-in Capital [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Successor [Member]

Note 11 - Stockholders' Equity (Details) - Successor Equity Reconciliation from Inception [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Balance, shares (in Shares)

'

'

'

'

'

'

2,000,000

2,000,000

2,000,000

88,529,500

137,290,980

103,571,941

'

'

'

'

'

'

'

'

'

'

Balance

'

$1,626,201

'

$1,115,102

'

'

'

$20

'

'

$1,353

'

$881,267

$1,703,483

$1,212,038

($80)

($202,016)

($194,222)

$881,187

$1,626,201

$1,626,201

$1,115,102

Issuance of stock, shares (in Shares)

88,500,000

1,251,744

16,244,694

'

1,999,998

'

2

'

'

88,529,500

3,959

'

'

'

'

'

'

'

'

'

'

'

Issuance of stock

'

'

'

'

20,000

20,000

'

'

'

885,296

'

'

885,296

44

'

'

'

'

'

'

44

'

Equity offering cost

'

'

'

'

'

'

'

'

'

'

'

'

-24,078

13,433

'

'

'

'

-24,078

'

13,433

'

Equity compensation expense

'

'

'

'

'

'

'

'

'

'

'

'

49

'

'

'

'

'

49

'

'

'

Net loss

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

($80)

($7,794)

'

($80)

$1,488

($4,460)

'

Note_11_Stockholders_Equity_De4

Note 11 - Stockholders' Equity (Details) - Successor Equity Reconciliation from Inception (Parentheticals) (Successor [Member], USD $)	Jun. 30, 2014	Jun. 30, 2013
Successor [Member]	'	'
Note 11 - Stockholders' Equity (Details) - Successor Equity Reconciliation from Inception (Parentheticals) [Line Items]	'	'
Issuance of stock, per share	$11	$10

Note_11_Stockholders_Equity_De5

Note 11 - Stockholders' Equity (Details) - Predecessor Reconciliation of Consolidated Changes in Equity (USD $)

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2013

Dec. 31, 2012

Jun. 30, 2013

Jun. 30, 2013

Dec. 31, 2012

Jun. 30, 2013

Dec. 31, 2012

Jun. 30, 2013

Dec. 31, 2012

Jun. 30, 2013

Dec. 31, 2012

Jun. 30, 2013

Dec. 31, 2012

Jun. 30, 2013

Dec. 31, 2012

Jun. 30, 2013

Dec. 31, 2012

Jun. 30, 2013

Jun. 30, 2013

Dec. 31, 2012

In Thousands, unless otherwise specified

Series A Preferred Stock [Member]

Series A Preferred Stock [Member]

Series B Preferred Stock [Member]

Common Stock [Member]

Common Stock [Member]

Additional Paid-in Capital [Member]

Additional Paid-in Capital [Member]

Retained Earnings [Member]

Retained Earnings [Member]

Accumulated Other Comprehensive Income (Loss) [Member]

Accumulated Other Comprehensive Income (Loss) [Member]

Treasury Stock [Member]

Treasury Stock [Member]

Parent [Member]

Parent [Member]

Noncontrolling Interest [Member]

Noncontrolling Interest [Member]

Predecessor [Member]

Predecessor [Member]

Predecessor [Member]

Preferred Stock [Member]

Preferred Stock [Member]

Preferred Stock [Member]

Predecessor [Member]

Predecessor [Member]

Predecessor [Member]

Predecessor [Member]

Predecessor [Member]

Predecessor [Member]

Predecessor [Member]

Predecessor [Member]

Predecessor [Member]

Predecessor [Member]

Predecessor [Member]

Predecessor [Member]

Predecessor [Member]

Predecessor [Member]

Predecessor [Member]

Predecessor [Member]

Predecessor [Member]

Note 11 - Stockholders' Equity (Details) - Predecessor Reconciliation of Consolidated Changes in Equity [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Balance

$1,626,201

$1,115,102

'

$525,027

$45,244

$49,583

$50,000

$2,396

$2,318

($284,765)

($273,086)

($52,670)

($30,270)

'

($1,264)

($240,212)

$272,725

($427)

($288)

($240,639)

($240,639)

$272,437

Net income

'

'

'

'

'

'

'

'

'

9,393

'

'

'

'

'

9,393

'

180

'

-5,764

9,573

'

Equity compensation (in Shares)

'

'

'

'

'

'

'

78

'

'

'

'

'

'

'

78

'

'

'

'

78

'

Accrual of paid in kind dividend on cumulative preferred shares

'

'

20,805

'

267

'

'

'

'

-21,072

'

'

'

'

'

'

'

'

'

-9,278

-21,072

'

Foreign currency translation adjustments

'

'

'

'

'

'

'

'

'

'

'

-22,009

'

'

'

-22,009

'

-32

'

'

-22,041

'

Derivatives valuation, net of tax benefit of $227

'

'

'

'

'

'

'

'

'

'

'

-423

'

'

'

-423

'

'

'

'

-423

'

Unrealized loss on available for sale equity securities, net of tax expense of $17

'

'

'

'

'

'

'

'

'

'

'

32

'

'

'

32

'

'

'

'

32

'

Shares repurchased

'

'

-500,000

'

'

'

'

'

'

'

'

'

'

-8

'

-500,008

'

'

'

'

-500,008

'

Shares exchanged

'

'

-44,977

'

44,977

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Shares canceled (in Shares)

'

'

-855

'

'

-417

'

'

'

'

'

'

'

1,272

'

'

'

'

'

'

'

'

Dividend paid to non-controlling interest partner

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-304

'

'

-304

'

Contribution from non-controlling interest

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$17

'

'

$17

'

Note_11_Stockholders_Equity_De6

Note 11 - Stockholders' Equity (Details) - Predecessor Reconciliation of Consolidated Changes in Equity (Parentheticals) (Predecessor [Member], USD $)	3 Months Ended	6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2013	Jun. 30, 2013
Predecessor [Member]	'	'
Note 11 - Stockholders' Equity (Details) - Predecessor Reconciliation of Consolidated Changes in Equity (Parentheticals) [Line Items]	'	'
Tax benefit	($45)	$227
Tax expense	'	$17

Note_11_Stockholders_Equity_De7

Note 11 - Stockholders' Equity (Details) - The Income Tax Provision (Benefit) Allocated to the Components of Other Comprehensive Income (USD $)	3 Months Ended	6 Months Ended	3 Months Ended	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2013
	Successor [Member]	Successor [Member]	Predecessor [Member]	Predecessor [Member]
Note 11 - Stockholders' Equity (Details) - The Income Tax Provision (Benefit) Allocated to the Components of Other Comprehensive Income [Line Items]	'	'	'	'
Unrealized gain loss on available for sale securities	($20,000)	($2,000)	$33,000	($17,000)
Pension and postretirement plans	'	11,000	'	'
Derivative valuation	73,000	63,000	-45,000	227,000
Income tax benefit (provision) related to other comprehensive income	$53,000	$72,000	($12,000)	$210,000

Note_12_Earnings_Per_Share_Det

Note 12 - Earnings Per Share (Details) (Predecessor [Member])	6 Months Ended
	Jun. 30, 2014
Predecessor [Member]	'
Note 12 - Earnings Per Share (Details) [Line Items]	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	0

Note_12_Earnings_Per_Share_Det1

Note 12 - Earnings Per Share (Details) - Weighted Average Shares Outstanding (USD $)	2 Months Ended	3 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2013	Jun. 30, 2014
Weighted Average Shares Outstanding [Abstract]	'	'
Net income attributable to common shareholders (in Dollars)	($7,794)	($376)
Basic weighted average common shares outstanding	117,937	128,595
Dilutive weighted average common shares outstanding 1	117,937	128,595

Note_12_Earnings_Per_Share_Det2

Note 12 - Earnings Per Share (Details) - Weighted-Average Stock Options and Warrants Not Included in the Computation of Diluted Shares Outstanding	3 Months Ended	6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2014
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Weighted average stock options and warrants	22,857	25,635
Contingently Issuable Shares for the Founder Preferred Share Dividend Right [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Weighted average stock options and warrants	11,279	11,279
Shares Issuable Upon Conversion of PDH Non-controlling Interest [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Weighted average stock options and warrants	8,775	8,775
Shares Issuable Upon Conversion of Founder Preferred Shares [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Weighted average stock options and warrants	2,000	2,000
Contingently Issuable for the Contingent Consideration [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Weighted average stock options and warrants	713	713
Warrant [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Weighted average stock options and warrants	'	2,243
Shares Issuable Upon Conversion of 401k Exchange Rights [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Weighted average stock options and warrants	'	544
Equity Option [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Weighted average stock options and warrants	88	80
Restricted Stock Units (RSUs) [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Weighted average stock options and warrants	2	1

Note_13_Contingencies_Environm2

Note 13 - Contingencies, Environmental and Legal Matters (Details) (USD $)	Jun. 30, 2014	Dec. 31, 2013	Jul. 08, 2014	Jul. 08, 2014	Jul. 08, 2014	Jul. 08, 2014
In Thousands, unless otherwise specified			Anti-Trust Damages [Member]	Breach of Contract Damages [Member]	Misappropriation of Trade Secrets [Member]	Punitive Damages for Unfair Trade Practices [Member]
			Subsequent Event [Member]	Subsequent Event [Member]	Subsequent Event [Member]	Subsequent Event [Member]
Note 13 - Contingencies, Environmental and Legal Matters (Details) [Line Items]	'	'	'	'	'	'
Asset Retirement Obligation	$5,364	$4,765	'	'	'	'
Reserves for Environmental Contingencies	2,250	2,896	'	'	'	'
Loss Contingency, Damages Awarded, Value	'	'	3,941	7,904	3,791	11,875
Loss Contingency, Estimate of Possible Loss	$3,293	$2,881	'	'	'	'

Note_13_Contingencies_Environm3

Note 13 - Contingencies, Environmental and Legal Matters (Details) - Outstanding Legal Reserves (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Note 13 - Contingencies, Environmental and Legal Matters (Details) - Outstanding Legal Reserves [Line Items]	'	'
Other long-term liabilities	$35,956	$30,387
	5,364	4,765
Legal Reserve [Member]	'	'
Note 13 - Contingencies, Environmental and Legal Matters (Details) - Outstanding Legal Reserves [Line Items]	'	'
Accrued expenses and other current liabilities	463	69
Other long-term liabilities	$4,901	$4,696

Note_14_Income_Taxes_Details

Note 14 - Income Taxes (Details) (USD $)	1 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014
Income Tax Disclosure [Abstract]	'
Unrecognized Tax Benefits	$7.60
Undistributed Earnings of Foreign Subsidiaries	23.7
Deferred Tax Liability Reduction in Valuation	$4.50

Note_15_Related_Party_Transact1

Note 15 - Related Party Transactions (Details) (USD $)	1 Months Ended	3 Months Ended	6 Months Ended	0 Months Ended	6 Months Ended		3 Months Ended	6 Months Ended
	Oct. 31, 2013	Jun. 30, 2014	Jun. 30, 2014	Nov. 07, 2013	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2013	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2014	Oct. 31, 2013
	Mariposa Capital [Member]	Mariposa Capital [Member]	Mariposa Capital [Member]	Pershing Square [Member]	Court Square [Member]	Court Square [Member]	Weston Presidio [Member]	Weston Presidio [Member]	Seven-Year Period [Member]	MacDermid [Member]	MacDermid [Member]
									MacDermid [Member]
									Maximum [Member]
Note 15 - Related Party Transactions (Details) [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Business Acquisition, Shares Price Exchange Rate	'	'	'	'	'	'	'	'	'	$11	'
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High	'	'	'	'	'	'	'	'	100,000,000	100,000	100,000,000
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners	'	'	'	'	'	'	'	'	'	6.76%	'
Related Party, Notice of Non-Renewal to Agreement	'6 months	'	'	'	'	'	'	'	'	'	'
Professional Fees	'	500,000	1,000,000	'	'	'	'	'	'	'	'
Related Party, Ownership Percentage	'	'	'	24.30%	'	'	'	'	'	'	'
Management Fee Expense	'	'	'	'	$204,000	$102,000	$23,000	$47,000	'	'	'

Note_16_Restructuring_Activiti2

Note 16 - Restructuring Activities (Details) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Restructuring and Related Activities [Abstract]	'	'	'	'
Restructuring Charges	$404	$46	$404	$1,652
Restructuring Reserve, Current	$1,325	'	$1,325	'

Note_16_Restructuring_Activiti3

Note 16 - Restructuring Activities (Details) - Restructuring Expense (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Note 16 - Restructuring Activities (Details) - Restructuring Expense [Line Items]	'	'	'	'
Severance and other benefits	$404	$46	$404	$1,652
Successor [Member]	'	'	'	'
Note 16 - Restructuring Activities (Details) - Restructuring Expense [Line Items]	'	'	'	'
Severance and other benefits	404	'	404	'
Predecessor [Member]	'	'	'	'
Note 16 - Restructuring Activities (Details) - Restructuring Expense [Line Items]	'	'	'	'
Severance and other benefits	'	$46	'	$1,652

Note_16_Restructuring_Activiti4

Note 16 - Restructuring Activities (Details) - Activity in Restructuring Liabilities (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Restructuring Cost and Reserve [Line Items]	'	'	'	'
Balance	'	'	$2,029	$632
Charges to Expense	404	46	404	1,652
Cash Payments	'	'	-1,032	-755
Non-cash Adjustments	'	'	-76	-9
Balance	1,325	1,520	1,325	1,520
Graphic Solutions [Member] | Severance and Other Benefits [Member]	'	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'	'
Balance	'	'	699	'
Charges to Expense	'	'	179	1,508
Cash Payments	'	'	-291	-643
Balance	587	865	587	865
Graphic Solutions [Member]	'	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'	'
Balance	'	'	699	'
Charges to Expense	'	'	179	1,508
Cash Payments	'	'	-291	-643
Balance	587	865	587	865
Performance Materials [Member] | Severance and Other Benefits [Member]	'	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'	'
Balance	'	'	1,330	632
Charges to Expense	'	'	225	144
Cash Payments	'	'	-741	-112
Non-cash Adjustments	'	'	-76	-9
Balance	738	655	738	655
Performance Materials [Member]	'	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'	'
Balance	'	'	1,330	632
Charges to Expense	'	'	225	144
Cash Payments	'	'	-741	-112
Non-cash Adjustments	'	'	-76	-9
Balance	$738	$655	$738	$655

Note_17_Segment_Information_De

Note 17 - Segment Information (Details)	6 Months Ended
	Jun. 30, 2014
Segment Reporting [Abstract]	'
Number of Reportable Segments	2
Number of Major Product Lines	2

Note_17_Segment_Information_De1

Note 17 - Segment Information (Details) - Financial Information Regarding Each Reportable Segment (USD $)

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

In Thousands, unless otherwise specified

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2013

Performance Materials [Member]

Performance Materials [Member]

Performance Materials [Member]

Performance Materials [Member]

Graphic Solutions [Member]

Graphic Solutions [Member]

Graphic Solutions [Member]

Graphic Solutions [Member]

Successor [Member]

Successor [Member]

Predecessor [Member]

Predecessor [Member]

Successor [Member]

Successor [Member]

Predecessor [Member]

Predecessor [Member]

Successor [Member]

Successor [Member]

Predecessor [Member]

Predecessor [Member]

Net Sales:

'

'

'

'

'

'

'

'

'

'

'

'

Net Sales

$147,129

$290,240

$145,274

$284,098

$42,003

$82,618

$44,718

$88,026

$189,132

$372,858

$189,992

$372,124

Operating profit (loss):

'

'

'

'

'

'

'

'

'

'

'

'

Operating Profit (loss)

$16,641

$25,480

$27,115

$48,563

($11,035)

($15,882)

$9,517

$17,845

$5,606

$9,598

$36,632

$66,408

Note_18_Subsequent_Events_Deta

Note 18 - Subsequent Events (Details) (Subsequent Event [Member], Percival [Member], EUR €)	0 Months Ended
	Aug. 04, 2014
Note 18 - Subsequent Events (Details) [Line Items]	'
Business Combination, Consideration Transferred	€ 300,000,000
Payments to Acquire Businesses, Gross	285,000,000
Common Stock [Member]	'
Note 18 - Subsequent Events (Details) [Line Items]	'
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable	€ 15,000,000